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Abstract

No two individuals are identical. This is true at the genetic level
and at the phenotypic level. One of the traits that varies between
populations is toxicant susceptibility: some individuals are sensitive to
the effects of environmental chemical exposure, and others are
resistant. This body of work aims to address the impact of genomic copy
number variants (CNV)—large (>1 Kb) duplications or deletions across
the genome—on the toxicant-susceptibility phenotype.
Herein I have characterized copy number variants across three
commonly used laboratory strains of zebrafish (Danio rerio) and
identified mRNA expression phenotypes in the same strains. I found that
males and females have only a 14% overlap in differentially expressed
mRNA transcripts across three common laboratory strains, congruent
with the growing body of work identifying sex- and strain-specific
phenotypes in zebrafish. Furthermore, I identified two strain-specific
response quantitative trait loci (QTL) that explain about a third of the
variation in susceptibility to PCB and tested the response QTL using
targeted CRISPR-Cas9 editing of the CNV involved. Overall, this body of
work defines CNV and mRNA expression variation across zebrafish
strains, identifies CNV causal in the PCB-susceptibility phenotype, and
confirms the PCB-susceptibility QTL using targeted genomic editing.
i
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Chapter 1
An Introduction

Toxicology as a framework
In toxicology, risk is defined as the product of toxicity and
exposure, where exposure is comprised of both dose and duration. To
determine risk we perform a formal risk assessment, which is a highly
regulated process typically pertaining to human and/or environmental
health. Currently there are 97 formal guidance documents from the
United States Environmental Protection Agency (US EPA) that direct all
aspects of human health risk assessment. To determine the human
health risk of a compound, regulators follow four main steps of
assessment:

hazard

identification,

dose-response

assessment,

exposure assessment, and risk characterization1 (Figure 1.1).

1

Figure 1.1: The 4 steps of risk assessment. Dose-response and exposure
assessment are also collectively known as hazard assessment. Image
credit:
https://www.epa.gov/risk
conducting-human-health-riskassessment#main-content.
In human health risk assessment, hazard identification is initiated
through a literature review process where existing data are assessed for
evidence of potential health effects in humans, such as cancer or death.
The two key components of hazard identification, toxicokinetics and
toxicodynamics, include assessment of compound distribution (i.e.,
where it goes in the body), compound metabolism or elimination (i.e.,
how long it stays), and the effects that the chemical has on the body.
The US EPA focuses its hazard identification for potential carcinogens on
mode of action analysis, where the key chemical, molecular, cellular,
and organismal events are delineated and the “weight of evidence” of
adverse outcomes at any of the key events resulting in descriptors of
the compounds ability to induce carcinogenic effects in humans.
2

If a compound is deemed potentially hazardous, it is then
assessed for a dose-response relationship. Generally, as the dose
increases the biological response also increases, but there is a lower
limit at which adverse effects are not observed. This theory was
originally postulated by Paracelsus in the 15th century, who stated,
“solely the dose determines that a thing is not a poison”2, and manifests
in modern toxicology as two dose-response criterial: NOAEL and LOAEL.
The NOAEL is the no observable adverse effect level, where no adverse
effects are observed at a known concentration and the LOAEL is the
lowest observable adverse effect level. Similarly, the benchmark dose is
another measurement that involves modeling NOAEL and LOAEL data to
predict a single point-of-departure value where the dose induces a
response3.
Exposure assessment goes hand-in-hand with dose-response
assessment. At this step the extent of exposure is assessed: who is
exposed, at what interface is exposure occurring (skin, lungs, eyes,
etc.), and what is the duration of the exposure? Oftentimes it is quite
difficult to clearly delineate answers to these questions in humans, so
epidemiologic analyses and extrapolations from body burden studies are
used to estimate the dose experienced during exposure4.
The

final

step

in

human

health

risk

assessment

is

risk

characterization. This step integrates the conclusions from hazard
3

identification and hazard assessment (dose-response plus exposure)
into an overarching conclusion about the risk of the compound. The final
risk characterization is used by regulators and policy makers to direct
public health using data that support the extent and direction of human
health outcomes following exposure5. Risk characterization ultimately
shapes policy that directs the prioritization of legacy chemical clean-up
(e.g., PCB) and the introduction of new chemicals in commercial
application.
One of the most crucial aspects of risk assessment is setting a
reference dose for safe levels of exposure. Reference doses are
calculated using a point-of-departure estimate, such as NOAEL, LOAEL,
or benchmark dose, and applying uncertainty factors and modifying
factors (Equation 1.1).
𝑁𝑂𝐴𝐸𝐿

Equation 1.1: 𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑑𝑜𝑠𝑒 = 𝑢𝑛𝑐𝑒𝑟𝑡𝑎𝑖𝑛𝑡𝑦 𝑓𝑎𝑐𝑡𝑜𝑟
Uncertainty factors are determined on a case-by-case basis, but
consist of four main components with values ranging from 0.1-10:
human variability, animal to human extrapolation, sub-chronic data
(i.e.,

acute),

and

point-of-departure

uncertainty.

Additionally

a

modifying factor of up to a value of 10 can be assigned for the level of
completeness in the dataset used in the hazard assessment. Let’s look
4

at an example using an acute exposure study in rats to determine a
reference dose. In this study the authors determined a LOAEL of 0.1
mg/kg/day for their endpoint. To calculate a reference dose we would
take the LOAEL and divide it by the product of the uncertainty factors
(Equation 1.2).

Equation 1.2:
𝐿𝑂𝐴𝐸𝐿

𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑑𝑜𝑠𝑒 = 𝑈𝐹

ℎ𝑢𝑚𝑎𝑛 ∗𝑈𝐹𝑖𝑛𝑡𝑒𝑟𝑠𝑝𝑒𝑐𝑖𝑒𝑠 ∗𝑈𝐹𝑠𝑢𝑏−𝑐ℎ𝑟𝑜𝑛𝑖𝑐 ∗𝑈𝐹𝑃𝑜𝑖𝑛𝑡 𝑜𝑓 𝑑𝑒𝑝𝑎𝑟𝑡𝑢𝑟𝑒 ∗𝑀𝐹𝑑𝑎𝑡𝑎𝑏𝑎𝑠𝑒

The uncertainty factors for human variation (UFhuman) and animal
to

human

extrapolation

(UFinterspecies)

can

both

be

split

into

toxicodynamic and toxicokinetic subsets, but in this case we don’t have
any information on either uncertainty factor, so their values will both be
assigned the maximum value of 10. Because our rat study was not a
chronic study we need to include a sub-chronic uncertainty factor of 10
(UFsub-chronic) and because we used a LOAEL value and not a NOAEL value
(i.e., there was no NOAEL identified in our rat study) we also need to
include a point-of-departure uncertainty factor of 10 (UFpoint of departure).
Finally, this is the only study that has been performed on our compound
of interest, so the breadth of data is extremely lacking and we need to
assign a modifying factor of 10 (MFdatabase). In this case our final
5

reference dose would be 1 ng/kg/day in humans (see worked example).
So at 1 ng/kg/day we would not expect to see any adverse health
outcomes in humans. This is an extremely conservative estimate and
may not accurately reflect the true biology and toxicology of the
compound.

Worked example:
𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑑𝑜𝑠𝑒 =

𝑚𝑔
/𝑑𝑎𝑦
𝑘𝑔

0.1

10∗10∗10∗10∗10

=

𝑚𝑔
/𝑑𝑎𝑦
𝑘𝑔

0.1

100,000

𝑛𝑔

= 1 𝑘𝑔 /𝑑𝑎𝑦

One of the areas in which we can refine our uncertainties when
determining reference dose is human variation. Toxicodynamic and
toxicokinetic properties are both influenced by genetic variation. A study
investigating the toxicity and efficacy of methotrexate for the treatment
of psoriasis found genetic variants that caused changes in the number
of receptors for and transporters of the drug, which directly affected the
dynamics of the system6. Genetic polymorphisms in many isoforms of
cytochrome P450, a family of metabolic enzymes responsible for
xenobiotic metabolism, have been identified and linked to altered
metabolism

of

many

therapeutic

compounds7

(e.g.,

kinetics).

Understanding the normal variation that exists in humans and how it
affects the dynamics and kinetics of exposure would be a huge
6

advancement that could be directly translated into reference dose
calculations and the overall risk assessment procedure.

Harnessing human variation
In the last few decades huge strides have been made in human
genetics. In 2001 the first draft of the human genome was released 8
and as of 2017 the human reference genome is now in its 38 th release
(GRCh38) and contains alternate loci representing significant variation
in 178 regions9. Large scale efforts to identify global genetic variation
began with the HapMap Project in 2003, which focused on identifying
single nucleotide polymorphisms (SNPs) that were inherited as blocks10.
The HapMap Project was built on the foundation that many SNPs were
observed to exist in linkage disequilibrium and inherited as specific
haplotypes. Identification and classification of haplotypes would
decrease the number of SNPs required to identify variant regions specific
to

diverse

populations

and

facilitate

discovery

of

gene-disease

associations. In 2005 the first haplotype map of the human genome was
released and contained over 1 million SNPs11. In 2007 a second
generation haplotype map containing 3.1 million SNPs was released12
and in 2010 the International HapMap Consortium expanded their
dataset from 270 individuals from 4 global populations to 1,184
individuals from 11 global populations to sharpen the resolution on rare
7

variants and included the addition of genomic copy number variants
(CNVs)13.
As understanding of variation in the human genome grew and the
limitations of small sample sizes (<300 individuals) to detect rare
variants became apparent, a new large-scale genomic variation project
began. In 2008 the 1000 Genomes Project aimed to sequence at least
1000 individuals to investigate variants occurring in at least 1% of the
population with coverage of genic variants found at 0.1% of the
population14. In 2015 the 1000 Genomes Project had sequenced 2,504
people across 5 continents and 26 populations and found that the typical
genome differs from the human reference genome at 4.1-5.0 million
sites and variants differ greatly among populations15.

With this new

level of population variation, the 1000 Genomes Project established that
individual genomes contain 2,100-2,500 structural variants that affect
4-5 times as many nucleotides as SNPs and short insertion-deletions
(indels). Individuals harbor 18.4 Mb of structural variants per diploid
genome (8.9 Mb per haploid genome), largely comprised of multiallelic
CNV and biallelic deletions16.
CNV have shaped human diversity on the evolutionary scale by
imparting selective advantages or disadvantages17 through alteration of
gene expression by direct interaction (overlap with a gene) or indirect
regulatory mechanisms18. Moreover, most structural variants that alter
8

gene expression do so through enhancers and other regulatory elements
(88.3%), not through direct interaction with gene-coding regions19. In
human health, CNV are associated with Mendelian diseases (e.g.,
Charcot-Marie Tooth neuropathy20 and Williams-Beuren syndrome21),
complex diseases (e.g., diabetes22 and psoriasis23), and non-pathogenic
phenotypes (e.g., salivary amylase production24). Additionally, CNV
cause pharmacogenomic phenotypes25 where variable copy number
across xenobiotic metabolism genes alter the rate of metabolism
(pharmacokinetics) and if CNV interact with transporters or receptors
they can alter biological activity (pharmacodynamics).
In an effort to understand the effect of human variation on toxicity
and refine the human variation uncertainty factor in reference dose
determination, 179 chemicals were screened for cytotoxicity in
lymphoblastoid cell lines from 1,086 individuals from 9 populations
across 5 continents sequenced by the 1000 Genomes Project26. In this
study about half of the tested compounds had a range of toxicity that
would be captured by the 10½ uncertainty factor for interindividual
toxicodynamic variability when calculating reference doses. A portion of
the tested compounds had interindividual variation greater than a factor
of 10, indicating that the uncertainty factors are woefully inadequate for
some chemicals (Figure 1.2). Unfortunately, one of the weaknesses of
lymphoblastoid cell lines is CNV artifacts due to differences in replication
9

timing relative to primary cell lines27. This makes extrapolation of copy
number effects between systems extremely difficult.

Figure 1.2: B) Histogram of the toxicodynamic variability factor 10 (q50–
q01) for 149 compounds across 1,086 cell lines. The inset shows the
relationship between range and median estimated EC 10 for each
chemical. C) Cumulative distribution functions for the in vitro
toxicodynamic variability factor shrunken to account for technical
variability across 149 compounds and the human in vivo toxicodynamic
variability factors across 34 compounds28. D) Hierarchical clustering for
the 179-length profiles of mean EC10, computed within each population,
and shown by continental ancestral origin of the population. AM,
Americas. Image and description adapted from work by Abdo et al.,
201526.
Incorporating human variability is the next great challenge in
toxicology. There is clear evidence that the current practice of generic
10

uncertainty factors in reference dose calculations are inadequate, but
our knowledgebase of the driving factors behind interindividual
variability is also inadequate. Toxicity clades out by distinct genetic
populations (Figure 2c), indicating that toxicodynamic and toxicokinetic
phenotypes may be shared by genetically similar groups. It is an
extremely complex challenge to study this phenomenon in humans due
to uncontrollable confounding factors such as socio-economic and health
status. Other systems, including model organisms, may be the answer
to delineating the myriad factors involved in interindividual variation and
population-based variation, including the role that CNV play in toxicity.

Evidence of resistance to toxic chemicals in wild populations
Atlantic killifish (Fundulus heteroclitus) are estuarine fish found
along the coast of the Eastern United States. These fish have adapted
to local anthropogenic contamination in several locations such as
Newark Bay (New Jersey)29, the Elizabeth River (Virginia)30,

New

Bedford Harbor (Massachusetts)31, and the Hudson River (New York)32.
In each location, high levels of aryl hydrocarbon mixtures (largely
polychlorinated biphenyls, PCBs) are present in the sediments and are
generally toxic to resident organisms. At these locations, however,
Atlantic killifish have adapted to be resistant to high levels of pollution.

11

Different mechanisms have been tied to the resistant phenotype
in Atlantic killifish. Generally, tolerance is associated with a blockade of
the

aryl

hydrocarbon

receptor

(AHR)

signaling

pathway33.

Aryl

hydrocarbons, such as PCBs, impart toxicity through a highly conserved
AHR signaling cascade34 (Figure 1.3). Prior to ligand binding, AHR exists
in the cytosol bound to several chaperone proteins such as heat shock
protein 90 (HSP90), p23, and AHR-interacting protein (AIP). After
binding to a ligand, the AHR complex translocates to the nucleus where
it dissociates with the chaperone proteins and binds to AHR nuclear
translocator protein (ARNT). The AHR-ARNT complex then binds directly
with DNA at xenobiotic response elements (XREs) and induces
transcription of a suite of genes, including cytochrome P450 1A (CYP1A)
(reviewed in35). CYP1A and other cytochrome P450 proteins are
responsible for xenobiotic metabolism and both the parent compound
(AHR ligand) and its metabolites can exert toxic effects.

12

Figure 1.3: The AHR signaling cascade. After binding with a ligand, AHR
translocates to the nucleus, directly binds to the DNA at xenobiotic
response elements, and induces translation of a suite of genes, including
CYP1A. Adapted from Hall, 201434.
The genetic component of the toxicant susceptibility phenotype in
killifish was tested by a common-garden experiment in which tolerant
populations were reared in a clean environment for two generations to
isolate the heritable component of tolerance, and then challenged with
known concentrations of a specific PCB congener (PCB-126)36. The study
found that tolerance was heritable for up to two generations indicating
that the phenotype is genetically based. Further work identified adaptive

13

selection of SNPs across AHR genes—which are known mediators of
PCB-126 toxicity in killifish37—in the New Bedford Harbor population38.
The Atlantic Tomcod (Microgadus tomcod) is another example of
local adaptation to highly contaminated sites. Exposure to two aryl
hydrocarbons, benzo[a]pyrene and PCB-77, does not induce CYP1A
mRNA expression in fish from the contaminated site, but fish from a
nearby clean site have robust transcriptional responses to the same
exposure32 (Figure 1.4). The mechanism behind this resistance has been
identified as a 6 basepair deletion in the AHR2 gene that results in a two
amino acid deletion in the mature protein and is highly penetrant in
populations at polluted sites39.

Figure 1.4: CYP1A mRNA expression levels (mean and 95% CIs,
expressed in OD units) in juvenile tomcod from a contaminated (Hudson
River) and clean (Miramichi River) site injected intraperitoneally with 10
ppm Benzo[a]pyrene, corn oil vehicle, or 10 ppm PCB-77. Numbers
above bars represent sample size. Image and description adapted from
Yuan et al., 200632.
14

Repeated observations of toxicity-resistance

phenotypes in

multiple species are strong evidence of the adaptive advantage that
these populations have in polluted environments. The genome of the
Atlantic killifish was assembled in 2015 and a linkage map was published
shortly thereafter, facilitating a deeper understanding of the genetic
mechanisms behind the resistance phenotype. The genetic linkage map
identified 24 linkage groups (putative chromosomes) and supports a
high degree of synteny between killifish and medaka, with slightly less
synteny between killifish and zebrafish40. Although zebrafish are less
syntenic with killifish than medaka, they still share several quantitative
trait loci (QTL) identified as the genetic basis for aryl hydrocarbon
resistance in killifish41.

Zebrafish as a model system to study the effects of genetic variation on
toxicity
The Atlantic killifish and Atlantic tomcod are excellent examples of
repeated

evolution

of

a

toxicant-resistance

phenotype

through

convergent genetic mechanisms. However, the complete picture of the
genetics driving this phenotype is unclear due to unexplained variance
and a lack of genomic tools to discover the cause of the variance. Herein

15

lies the strength of the well-developed model organism, the zebrafish
(Danio rerio).
Zebrafish were first used as a model system in the 1940s and
following the establishment of several laboratory strains in the 1990s,
their popularity has exploded (Figure 1.5). Since the mid-2000s over
1000 studies using zebrafish are published every year (searchable in
NCBI PubMed using “zebrafish” or “Danio rerio” keywords) and that
number has only continued to grow. In 2017 the number of zebrafish
publications hit its current peak of 2940.

Figure 1.5: Publication count per year, as indexed by NCBI's PubMed
using "zebrafish" or "Danio rerio" as keywords.
The rise of zebrafish as a model system is due to several factors.
The zebrafish shares basic body design with other vertebrates. Zebrafish
reach sexual maturity by 3 months, which facilitates genetic crosses and
multi-generational studies. Housing and husbandry are relatively cheap
and easy. External fertilization, large clutches of eggs (averaging ~200
16

embryos per spawning event), clear bodies until juvenile stage, and
rapid development (primary organogenesis begins at 10 hours and is
complete by 48 hours42) make studying early development easier than
mammalian systems. The zebrafish also boasts a completely sequenced
genome with 71% of zebrafish genes having at least one homolog in the
human genome43. With a sequenced genome comes a complete set of
genetic tools such as morpholinos, CRISPR-Cas9, and transgenic
strains.
Additionally, zebrafish have a toxicant-resistance phenotype,
similar to the phenotype observed in Atlantic killifish and Atlantic
tomcod. Zebrafish larvae exposed to PCB-126 have ranges of
developmental toxicity between 9 and 336 ppb across genetically
distinct laboratory strains44 (Figure 1.6). This range of interstrain
variation exceeds a factor of 10, such as is used in reference dose
assessment, and can serve as a malleable laboratory model of toxicity
variation across populations. Although AHR2 was identified as one of the
genetic drivers of the resistance phenotype, only 24% of the phenotypic
variance could be explained by QTL, leaving a large gap in our
understanding of the full effects of genomic variation on toxicant
susceptibility.

17

Figure 1.6: Median effective concentration (EC50) of early-life stage
toxicity (abnormal looping of the heart, pericardial and yolk-sac edema,
reduced heart rate, impaired swim bladder inflation, and craniofacial
malformations). Branch lengths reflect genetic distance; numbers in
parentheses represent 95% confidence intervals. Image and description
adapted from Waits and Nebert, 201144.
There is a fair amount of information on the genetic variation
between common laboratory strains in zebrafish. Most of the focus has
been on SNP variants between strains. In fact, zebrafish strains clade
out with high support using SNP markers with over 37.9 million SNPs
currently described across the 1.5 Gb zebrafish genome45. Beyond SNPs,
there is also a detailed analysis of intrastrain CNV across three common
laboratory strains and one wild strain of zebrafish. Across strains, there
are approximately 1900-3400 CNV, of which only about 500 are shared
across all strains, indicating that strains have their own unique set of
CNV46, similar to the case with distinct human populations16. These
factors prime the zebrafish to be a uniquely helpful tool for basic
18

research into the genetic mechanisms driving complex phenotypes like
toxicant susceptibility.
To test the likelihood that CNV play a role in toxicant susceptibility,
I performed a basic assessment of direct and near-neighbor overlap of
CNV in zebrafish with a thorough list of 70 genes that are differentially
expressed in the toxicant-resistant Atlantic killifish phenotype relative
to toxicant-sensitive populations47. Using NCBI’s blastn alignment tool48
to assign zebrafish gene homologs (closest sequence match to the nr/nt
database with an e-value > 1 x 10-10), I found 9 genes (12.9%) with
directly overlapping CNV and 34 genes (48.6%) with a CNV within 100
Kb up- or downstream in zebrafish (Supplemental data 1.1). These
direct and near-neighbor hits indicate that CNV are likely interacting
with transcriptional responses that drive the toxicant-susceptibility
phenotype.

A brief history of PCBs
Polychlorinated biphenyls are a large class of aryl hydrocarbons
comprised of 209 congeners with varying levels of chlorination of a
biphenyl molecule (two connected benzene rings, Figure 1.7). PCBs are
characteristically hydrophobic and lipophilic, have low vapor pressures,
and are resistant to chemical reactions (including degradation)49. As the
number of chlorine molecules increases, the stability of the compound
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increases. These properties make PCBs excellent coolants, flame
retardants, and plasticizers, but also result in long half-lives and
bioaccumulation in the food web.

Figure 1.7: Chemical structure of PCB. Image from Crinnion, 201150.
There are two general classes of PCB congeners determined by
the position and number of chlorines: nonplanar (mono-orthosubstituted) and coplanar (non-ortho-substituted). Coplanar congeners
exert toxic dioxin-like effects by binding and activating the AHR
signaling cascade51,52. In 1979 the US EPA banned the production and
use of PCBs following evidence that bioaccumulation in birds caused
brittle shells through aberrant calcium metabolism, a large-scale
poisoning incident in Yusho, Japan where over 1000 people consumed
food cooked in contaminated cooking oil, and a forced cull of thousands
of chickens and eggs that were fed contaminated feed (as reviewed
in53).
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The World Health Organization developed a comparative scale to
assess the toxicity of dioxin and dioxin-like compounds called a Toxic
Equivalency Factor (TEF). Dioxin (2,3,7,8-TCDD) is set at the maximum
TEF of 1 and related compounds are assigned a TEF relative to dioxin
after review of published toxicity data54. The most toxic PCB listed in the
TEF documentation is PCB-126 (3,3’,4,4’,5-pentachlorobiphenyl) with a
TEF of 0.1. Other coplanar (non-ortho-substituted) PCBs have TEF
values between 0.03-0.0001, while nonplanar (mono-ortho-substituted)
PCBs have TEF values of 0.00003. PCB-126 is heavily chlorinated (with
5 chlorines) and has a half-life on the order of 20-30 years in adults55.
The total body burden of PCBs in humans has steadily declined
since the ban in 1979, but a national census of human exposure to
environmental chemicals by the US Centers for Disease Control and
Prevention (CDC) found 34 of 38 PCB congeners in virtually all people
tested56. The current body burden of PCB-126 in the average American
is 100 ppq in the serum (16.3 pg PCB-126/g lipid). In utero exposure to
PCBs can result in immune deficiency and neurological deficits and
dietary exposure (the most common route of exposure) can cause
reproductive problems in men and women, hypothyroidism, and
increases in the risk of type II diabetes, lung cancer, and liver cancer
(as reviewed in50).
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Because

of

its

highly

toxic

effects,

long-half

life,

and

bioaccumulative properties, PCB-126 serves as a good proxy for the
effects of total PCB burdens (from mixtures of multiple PCB congeners
with assumed additive effects) in controlled studies. There is extensive
documentation of the developmental effects of PCB-126 exposure across
multiple fish species, including zebrafish. In zebrafish, developmental
toxicity is largely characterized by pericardial and yolksac edema, delay
of swim bladder inflation, elongated and/or unlooped heart (abnormal
cardiac development), reduced heart rate, and malformation of the
spine57–59. These physical manifestations of PCB-126 toxicity are easily
observable in controlled laboratory studies. The combination of a clear
developmental toxicity paradigm for PCB-126 and well-characterized
genomic variation make the zebrafish the ideal system to assess the
influence of genetic variation on susceptibility to toxicants.

Rationale for chapters
Our current knowledge of CNV in zebrafish was built on withinstrain (intrastrain) comparisons. While this allows some comparison of
shared CNV across strains, it does not fully capture the interstrain
variability in zebrafish. To improve upon this I have assessed three
common laboratory strains of zebrafish using a reciprocal comparison
study design to maximize identification of interstrain variation. I present
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this work in Chapter 2 “An Interrogation of Shared and Unique Copy
Number Variants across Genetically Distinct Strains of Zebrafish”.
Herein I present a set of 1351 CNV that vary across strains and test a
set of ten identified CNV using multiple molecular methods (quantitative
PCR (qPCR) and long amplification standard PCR). I also present that
CNV that directly overlap a gene or fall within 5 Kb up- or downstream
of a gene are likely to cause variation across introns, coding sequence,
or untranslated regions at the start or end of genes.
Because we know that there is wide genetic variation across
zebrafish strains and I have predicted transcriptional effects of CNV that
vary across strains, we can hypothesize that there is also standing
variation in gene expression across strains. In Chapter 3 “Baseline
mRNA expression differs widely between common laboratory strains of
zebrafish” I characterize the normal transcriptional profiles in the same
set of commonly used zebrafish strains using microarrays. Surprisingly,
I found large differences between males and females, as well as large
differences between strains. A total of 421 unique mRNA transcripts
were significantly differentially expressed across strains. This study sets
the stage for further exploration of phenotypes affected by genetic and
transcriptional variation.
In Chapter 4 “Response eQTL analysis of low-dose PCB exposure
connects genomic copy number variants to susceptibility” I explore the
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relationship

between

genomic

CNV

and

the

PCB-susceptibility

phenotype. Using matched CNV genotypes and PCB-induced gene
expression phenotypes, I performed an extensive expression QTL
analysis to identify CNV drivers of the phenotype. After mapping
phenotypes of exposed and unexposed zebrafish to CNV, I found two
response QTL (eQTL responsive to PCB exposure) that are strainspecific.
To test the reQTL that I identified as drivers of the PCBsusceptibility phenotype, I performed a functional study using CRISPRCas9 to selectively edit the CNV in the two reQTL. In Chapter 5
“Targeted CRISPR-Cas9 Editing of Genomic Copy Number Modulates
PCB-Susceptibility Phenotype” I successfully target and edit the CNV
regions of both reQTL and show a reversion in phenotype where a PCBresistant strain becomes extremely sensitive and a PCB-sensitive strain
becomes slightly more resistant. This serves as proof-of-principle that
CNV play a role in modulation of toxicant susceptibility across
populations.
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Chapter 2
An Interrogation of Shared and Unique Copy Number Variants
across Genetically Distinct Zebrafish Strains

Abstract
Zebrafish (Danio rerio) are a widely utilized model system for
human

disorders,

but common laboratory strains

have

distinct

behavioral and physiological differences. Accompanying these known
strain differences, commonly used “wildtype” zebrafish strains have
both shared and unique suites of single nucleotide polymorphisms and
copy number variants (CNV). Despite this, genomic variation is often
ignored in study design and the strain used is often not mentioned. The
goal of this study is to assess CNV across three common laboratory
strains of zebrafish—AB, Tubingen (TU), and WIK—and provide this
dataset as a tool for the zebrafish community. Herein we identify 1351
CNV regions within the most recent genome assembly (GRCz11)
covering 1.9% of the zebrafish genome (31.7 Mb). CNV were found
across all chromosomes and 2200 genes (5121 transcripts) lie within ±
5 Kb of identified CNV, pointing to likely cis regulatory actions of CNV
on nearby gene neighbors. We have created a Public Session accessible
on the UCSC Genome Browser to view CNV from this study titled
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“danRer11 zebrafish CNV across strains” as a tool to view CNV for the
zebrafish community.

Introduction
Zebrafish

are

an

important

genetic

model,

but

the

acknowledgement and incorporation of genomic variation across
common lab strains into study design has been slow. It is well
established that zebrafish strains contain many shared and unique
single nucleotide polymorphisms (SNPs)45,60–62 and copy number
variants (CNVs)46,63 with several groups diligently working to describe
and characterize differences between strains at the genotypic and
phenotypic levels. The phenotypic effects of these genetic differences
are not well understood and likely manifest as observable, but as-of-yet
unidentified, variation between strains. To this end, several studies have
described behavioral and physiological differences between strains such
as differences in sex-determination64, fear-related behavior65, social
preference66, stress67, susceptibility to toxicants44, locomotion68, and
growth performance69.
CNV, which cover 5-10% of the human genome70, can directly and
indirectly affect gene expression via gene dosing71 and principally act
through enhancers and other regulatory elements19. CNV can be
positively or negatively correlated with gene expression72 and result in
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wide-ranging phenotypic effects like testosterone metabolism73, the
ability to digest starch24, or complex diseases such as autism and
schizophrenia (reviewed in74,75). As zebrafish continue to grow as an
important model system for basic research, it is imperative to expand
our knowledge of the genomic variation within the species. Previous CNV
identification

in

zebrafish

focused

on

within-strain

(intrastrain)

variation. This study aims to describe zebrafish genomic copy number
variation

across

commonly

used

laboratory

strains

(interstrain

variation). By providing these data to the global zebrafish community,
we hope to highlight the important role that copy number variation has
on phenotypes across strains in support of incorporating this information
into study design and publication. This is of critical importance to the
zebrafish community because clearly defining genomic variation will
result in better replication and translation of our research into other
model systems, for human health applications, and for application to
ecological systems.

Materials and Methods
Animal care and husbandry
All zebrafish husbandry and experimental procedures were
performed following protocols approved by Portland State University’s
Institution Animal Care and Use Committee in accordance with the
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National Institutes of Health Guidelines for Care and Use of Laboratory
Animals and the Public Health Service Policy on Humane Care and Use
of Laboratory Animals. Zebrafish were housed on an Aquaneering semirecirculating housing system at a density of 5 individuals per liter with
10% daily water changes. Water temperature was maintained at 27.5°C
and fish were kept on a 16 hour light, 8 hour dark photoperiod. pH and
conductivity were maintained at approximately 7.4 and 1100 uS,
respectively. Zebrafish were fed commercial flake food twice daily and
supplemented with live Artemia and rotifers. This study used 3 strains
of zebrafish: AB, Tuebingen (TU), and WIK.

aCGH data analysis
Microarray data were obtained from the National Center for
Biotechnology Information (NCBI) BioProject portal (GEO Sample IDs:
GSM839719, GSM839720, GSM839721)46. Array data are comprised of
pooled DNA from 10 individuals each of AB, TU, and WIK strains run in
a reciprocal design (AB vs TU, WIK vs TU, AB vs WIK) on customdesigned Aligent Technologies SurePrint GS CGH microarrays. Arrays
were designed against the zebrafish Zv8/danRer6 reference genome
and had an average probe spacing of 1.4 kb. Copy number variants
(CNV) were called using normalized signal intensity files within Nexus
Copy Number software (version 5.1; BioDiscovery) and reported as log2
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ratios. Log2 ratios with a three-probe running average greater than 2
were identified as CNVs46. Microarray probe chromosomal locations were
updated to the most recent zebrafish reference genome using the
LiftOver tool in UCSC Genome Browser76 (Zv8  Zv9  GRCz10 
GRCz11).

qPCR and standard PCR
Quantitative PCR (qPCR) was performed across 10 regions
identified as having a CNV using primers designed on Primer3Plus
software77. DNA was isolated via standard phenol:chloroform extraction
for 10 individuals from each strain and assayed across the 10 regions in
triplicate on a 364-well plate format using Power SYBR Green Master
Mix (Applied Biosystems). Fluorescence was measured on an Applied
Biosystems 7900HT Real-Time PCR System. The qPCR cycling protocol
included preliminary dissociation (10 minutes at 95°C) and 35 cycles of
annealing and extension (95°C for 15 seconds, 60°C for 30 seconds),
per manufacturer’s protocol. A dissociation melt curve was also obtained
to confirm single PCR products. Quantification of PCR product was
performed using the ∆∆Ct method78 with an ultra-conserved element
(UCE) as a standardized DNA copy number reference sequence46 and
pooled DNA from AB, TU, or WIK strains as reference for each strain.
Specifically, ∆CT = target - UCE and ∆∆CT = ∆CTindividual - ∆CTpool.
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Pairwise comparisons were made between each strain and fold change
was calculated as the inverse log2 of ∆∆CT (or 2-∆∆CT).
Standard PCR was performed across 3 CNV regions confirmed by
qPCR as an additional confirmation technique and further resolution of
the region using Hot Start Taq 2X Master Mix (New England BioLabs)
following the manufacturer’s protocol. DNA from 3 individuals per strain
was extracted using a DNeasy Blood and Tissue kit (Qiagen). PCR
products from 3 or 4 regions across each CNV were run on 1% agarose
gels with Gel Red nuclear binding stain in 0.5X TBE at 110 volts for 45
minutes and visualized on a digital gel imager. Bands were scored as
present/absent and approximate size was noted. All qPCR and standard
PCR primers, amplicon sizes, and locations are listed in Supplementary
Table 2.1.

Predicting effects of CNV
Consequences of identified CNV were predicted using the Ensembl
Variant Effect Predictor79. Briefly, effects of CNV were predicted for all
RefSeq genes and transcripts falling within a very conservative zone of
5 kb up- or downstream of the CNV location. CNV calls from the GRCz10
assembly were used for this analysis as this is the most recent genome
version available for use with the tool.
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Results
Across the reciprocal comparisons of pooled DNA from three
zebrafish strains, we identified 1941 CNV regions in the Zv8 genome
(Supplementary Table 2.2). Stepwise LiftOver to GRCz11 resulted in the
loss of CNV calls due to a split across the region or partial deletion in
newer versions of the reference genome. The largest loss in CNV calls
resulted from the Zv8 to Zv9 LiftOver because of a major genome
update. Zv9 to GRCz10 and GRCv10 to GRCz11 LiftOvers also resulted
in the loss of some, but fewer, CNV calls. The final count of GRCz11 CNV
calls was 1351 (Table 2.1) and the identified CNV regions nonredundantly cover 1.9% of the zebrafish genome (31.7 Mb).

Table 2.1: Summary of copy number count and type across four versions
of the zebrafish reference genome.

High Copy Gain
Copy Number Gain
Copy Number Loss
Homozygous Copy Loss
Partially deleted in new
Split in new

Zv8
432
1036
154
319
---

Zv9 GRCz10 GRCz11
375
355
350
731
631
626
128
116
112
291
265
263
5
4
3
411
154
13

We chose 10 random CNV regions to confirm by qPCR and further
interrogate the putative effects of those CNV on the organism (Figures
2.1 and 2.2). Of the 10 regions, 8 were fully confirmed by qPCR. Three
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regions showed a loss in WIK (CNV_0311, CNV_0437, CNV_0968), two
regions showed a gain in TU (CNV_0222, CNV_0900), two regions
showed a loss in AB (CNV_0559, CNV_1736), and one region showed a
loss in TU (CNV_0663). The data for one region (CNV_0302) were in
disagreement; the array data and CNV call identified a loss in AB while
the qPCR data showed a gain in TU. CNV_0572 was predicted to be a
loss in WIK from array data, but qPCR failed to show any differences
between strains. We further interrogated 3 of these regions by PCR to
obtain a high resolution understanding of the loci (Figure 2.3) and were
able to confirm the CNV across sub-regions approximately 3.7 Kb in size
for CNV_0222, CNV_0311, and CNV_0900. Not all CNV are fully
penetrant, as can be seen in CNV_0900.4 which as a gain in WIK across
the sub-region (in addition to the gain in TU).
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Figure 2.1: log2 ratios of microarray probes across chromosomal
locations identified as CNV with corresponding qPCR log2 fold-change
values. CNV_0222 = gain in TU, CNV_0302 = disagreement between
CNV (loss in AB) and qPCR (gain in TU), CNV_0311 = loss in WIK,
CNV_0437 = loss in WIK, CNV_0559 = loss in AB. Grey regions on log2
ratio plots indicate location of CNV. Error bars represent standard
deviation and large error bars indicate variation within the strain (i.e.,
the loss or gain is not fully penetrant).
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Figure 2.2: log2 ratios of microarray probes across chromosomal
locations identified as CNV with corresponding qPCR log2 fold-change
values. CNV_0572 = not validated, CNV_0663 = loss in TU, CNV_0900
= gain in TU, CNV_0968 = loss in WIK, CNV_1736 = loss in AB. Grey
regions on log2 ratio plots indicate location of CNV. Error bars represent
standard deviation and large error bars indicate variation within the
strain (i.e., the loss or gain is not fully penetrant).

Figure 2.3: Standard PCR across subsets of three CNV regions. Each PCR
amplicon was approximately 3.7 kb in length. CNV_0222 is only present
in TU, while CNV_0311 and CNV_0900 show some variation across
strains, but the array-based CNV call is confirmed by qPCR and PCR data
across multiple individuals.
CNV were identified across all chromosomes, with the highest
number of calls falling on chromosomes 3, 4, and 7 (Figure 2.4). We
have created a Public Session accessible on the UCSC Genome Browser
for the zebrafish community to view CNV data from this study titled
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“danRer11 zebrafish CNV across strains” (as an example, see Figure
2.5). Using the Ensembl Variant Effect Predictor we queried 1355 CNV
(GRCz10) against the RefSeq database and found 2200 genes and 5121
transcripts within ± 5 Kb of identified CNV. Of these genes and
transcripts located proximal to CNV regions, 25% resulted in intron
variants, 16% resulted in coding sequence variants, and 21% impacted
3’ or 5’ UTRs (Figure 2.6 and Supplementary Table 2.3).

Figure 2.4: Copy number counts across all chromosomes in GRCz11 by
type (Homozygous copy loss, copy number loss, copy number gain, or
high copy gain.

Figure 2.5: UCSC Genome Browser view of chromosome 4 (GRCz11)
with CNV locations in teal, RefSeq Genes in blue, and GenBank mRNAs
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in
black.
Freely
available
at
https://genome.ucsc.edu/cgibin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=holdenl
&hgS_otherUserSessionName=danRer11%20zebrafish%20CNV%20acr
oss%20strains.

Figure 2.6: Predicted consequences of CNV that occur within 5 kb ± of
RefSeq transcripts (GRCz10) using the Ensembl Variant Effects
Predictor.
Discussion
In an effort to understand the effects of CNV on common lab
strains, we searched for available datasets reflecting structural variation
in zebrafish. The current NCBI structural variation database (dbVar,
www.ncbi.nlm.nih.gov/dbvar) contains only human and great ape
datasets and wholly excludes zebrafish data. The majority of available
datasets incorporating CNV and phenotype are from humans, where
much work has been done to associate structural variants to disease
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phenotypes. The EMBL-EBI Database of Genomic Variants archive
(DGVa, www.ebi.ac.uk/dgva) contains 200 genomic structural variant
studies, but only a single study utilizes zebrafish (study ID: nstd62).
The design of the single zebrafish study in DGVa used within population
comparisons to identify strain-specific structural variation, and then
used a subtractive model to infer between strain differences46. Therefore
the majority of the structural variation presented in that study is withinstrain (intrastrain) variation. We also found one previous study that
looked at copy number variation in the wild zebrafish strain ASWT80, but
the strain is not widely used so the data are not directly applicable to
most zebrafish investigators. Interestingly, we found no overlap in their
copy number deletion or insertion loci with our dataset, which indicates
that CNV are highly strain-specific.
This study performed reciprocal comparisons between three
common laboratory strains (AB, TU, and WIK) and found 1351 CNV
regions covering 1.9% (31.7 Mb) of the current zebrafish genome
assembly (GRCz11). The effects of these CNV on phenotype are not fully
known, but 2200 genes comprised of 5121 transcripts fall within ± 5 kb
of identified CNV. From studies in humans, we know that CNV can alter
gene expression, often by acting through regulatory elements from up
to 1 Mb away72, so the impact of these CNV is probably much larger
than the 2200 genes that fall within 5 Kb. With over 5000 transcript
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variants within 5 Kb up- or downstream of CNV, we predict that the
expression of many of these transcripts likely vary across strains,
dependent on copy number status. Previous work that characterized the
CNV within strains found CNV cover approximately 15% of the zebrafish
genome,

but

the

experimental

design

focused

on

within-strain

variation46. This analysis used pooled sample arrays (n=10 individuals
per strain) and likely reduces the level of interstrain variation detected
as only the most common variants are likely to be identified. We found
1.9% of the zebrafish genome to be affected by high-confidence CNV
that are unique across strains and have made these CNV loci available
to the zebrafish community for further exploration.
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Chapter 3
Baseline mRNA expression differs widely between common
laboratory strains of zebrafish
Published in Scientific Reports, 8, 1–10 (2018).

Abstract
Common strains of wildtype zebrafish (Danio rerio) have unique
genomic features including SNPs and CNV, but strain information often
goes unreported in the literature. As a result, the confounding effects of
interstrain variation makes repetition of studies in zebrafish challenging.
Here we analyze hepatic mRNA expression patterns between three
common zebrafish strains (AB, Tuebingen (TU), and WIK) using Agilent
4x44K gene expression microarrays to establish baseline mRNA
expression across strains and between sexes. We observed wide
variation in sex-specific gene expression within AB and WIK strains (141
genes in AB and 67 genes in WIK), but no significant variation between
sexes within TU. After partitioning the dataset into male and female
subsets, we detected 421 unique mRNA transcripts with statistically
significant differential expression; 269 mRNA transcripts varied between
males, 212 mRNA transcripts varied between females, and 59 mRNA
transcripts varied across the three strains, regardless of sex. It is not
surprising that mRNA expression profiles differ between sexes and
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strains, but it is imperative to characterize the differences. These results
highlight the complexity of variation within zebrafish and underscore the
value of this model system as a valid representation of normal variation
present in other species, including humans.

Introduction
Laboratory strains of zebrafish (Danio rerio) have discrete
genomic backgrounds; they clade out with very high bootstrap support
by distinct SNPs61 and have unique sets of copy number variant genomic
regions46. Because of these genomic traits, zebrafish strains may be able
to serve as a proxy to incorporate genetic variation into study design,
similar to our understanding of the genomic variation in distinct human
populations81. The human 1000 Genomes Project found that many
common genetic variants are shared across populations, but rarer
variants are generally only shared by closely related populations15.
Analogous to distinct human populations, zebrafish strains have unique
origin stories and genetic isolation between strains is maintained by
strict husbandry practices.
Commonly used zebrafish strains such as AB (ZFIN ID: ZDBGENO-960809-7), Tuebingen (TU; ZFIN ID: ZDB-GENO-990623-3), and
WIK (ZFIN ID: ZDB-GENO-010531-2) have well-documented histories
(Figure 3.1) and are easily obtainable for laboratory manipulations. The
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AB line began from unknown zebrafish source stocks bought from two
pet shops (pet shop A and pet shop B) in Albany, Oregon in the early
1970s82. Haploid progeny from AB females were crossed with random
AB males for approximately 70 generations until the early 1990s when
six diploid progeny stocks (each from a distinct haploid female) were
thoroughly intercrossed to produce the modern AB line (sometimes
referred to as AB*). The current AB source stock is maintained through
large group spawning crosses. The TU strain originated from a
composite population of fish purchased from pet shops in 1994 and was
maintained as an inbred strain in a lab in Tuebingen, Germany83,84. The
WIK strain (“Wild India Kolkata”) originated from a single pair mating of
wild caught fish in 199785. The establishment and maintenance of these
different strains has resulted in a similar observable phenotype.
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Figure 3.1: History of strain establishment for common laboratory
strains of zebrafish. AB, TU, and WIK are three popular zebrafish strains
used in genetic, developmental, and toxicological research with very
different origin stories.
The high homology between humans and zebrafish—71% of
human genes have at least one zebrafish ortholog and 69% of zebrafish
genes have at least one human orthologs43—makes zebrafish an
excellent model to study development, genetics, and toxicology.
Unfortunately only 83% of transgenic and 46% of non-transgenic wild
type strains of animal models are actually identified in the published
literature86 indicating that strain-based genetic variation is largely
overlooked or ignored. Behavioral traits associated with domestication
in wild versus lab-reared zebrafish are associated with differential mRNA
44

expression in the brain65, indicating that the genetic isolation and
population bottleneck inherent during laboratory strain establishments
of zebrafish can create distinct characteristics between strains. Sex is
an additional factor that drives differential mRNA expression between
strains, mostly associated with hormone biosynthesis87. The goal of this
study is to identify baseline liver mRNA expression variation between
different zebrafish strains and between sexes in support of the growing
recognition of normal variation between strains and populations88,89 in
an organismal and physiological context to support zebrafish as a strong
model for translational research.

Methods
Animal care and husbandry
All zebrafish husbandry and experimental procedures were
performed following protocols approved by Portland State University’s
Institution Animal Care and Use Committee in accordance with the
National Institutes of Health Guidelines for Care and Use of Laboratory
Animals and the Public Health Service Policy on Humane Care and Use
of Laboratory Animals. Zebrafish are housed on an Aquaneering semirecirculating housing system at a density of 5 individuals per liter with
10% daily water changes. Water temperature is maintained at 27.5°C
and fish are kept on a 16 hour light, 8 hour dark photoperiod. pH and
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conductivity are maintained at approximately 7.4 and 1100 µS,
respectively. Zebrafish are fed commercial flake food twice daily and
supplemented with artemia and rotifer live food. AB, TU, and WIK strains
are maintained in-house by random single pair breeding. Larvae are
screened for developmental abnormalities and 10 individuals from 25
pairs are randomly selected for the succeeding generation. The fish used
in this study were second generation adults originally sourced from ZIRC
(Eugene, OR) as batches of 100 embryos. All tissues were collected from
healthy adults between 12 and 14 months old. At the time of dissection
males weighed 331.7 ± 100.4 mg (mean ± SD) and females weighed
346.6 ± 90.7 mg. Male liver weights ranged from 0.002-0.021% of
whole body weight and female liver weights ranged from 0.003-0.028%
of whole body weight.

Nucleic acid isolation
White muscle and liver tissues were dissected from 3 males and 3
females from AB, TU, and WIK strains (n=6/strain; n=18 total) and
disrupted with a mortar and pestle prior to homogenization by passing
the samples through a nuclease-free syringe and needle in betamercaptoethanol lysis buffer. DNA was extracted on Qiagen DNeasy
columns (Qiagen, Valenica, CA, USA) and total RNA was extracted on
Qiagen RNeasy columns. Nucleic acid concentrations were determined
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on a Nanodrop Spectrophotometer 2000 (Thermo Scientific, Wilminton,
DE, USA). Both DNA and RNA exhibited high 260/280 ratios of 1.92 ±
0.04 and 2.10 ± 0.03, respectively (average ± SD), indicating adequate
quality for downstream analysis.

mRNA expression arrays
Commercially available 4x44K zebrafish mRNA expression arrays,
RNA spike-in kit, and Low Input Quick Amp one-color labeling kit
(Agilent) were used following manufacturer’s protocols. In brief, cDNA
was synthesized from RNA and transcribed into cRNA using Cyanine-3
fluorescent dCTP. Labeled cRNA was purified using a Qiagen RNeasy
mini kit per the manufacturer’s protocol and quantified on a NanoDrop
spectrophotometer. Samples with total cRNA yields greater than 1.65
µg and specific activity greater than 6 pmol Cy3/µg were fragmented,
hybridized to array slides at 65°C for 17 hours, washed briefly, and
scanned on an Agilent SureScan array scanner using grid file
026437_D_F_20140627 and scan protcol AgilentHD_GX_1Color. Data
were extracted from raw TIFF files using FeatureExtraction software
(Agilent) and spot brightness values were loaded into R. Raw microarray
data files and derived expression values are archived at the Gene
Expression

Omnibus

(https://www.ncbi.nlm.nih.gov/geo)

accession number GSE100583.
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under

Data normalization, analysis, and annotation
Data were cleaned by subtracting background fluorescence,
normalizing across arrays, and averaging duplicate probes within the
limma package90 using R91 version 3.3.2. Principal component analysis
using the prcomp() function within base R (v.3.3.2) was performed
using cleaned data (center = TRUE, scale = TRUE) and illustrated an
overlapping, but clear, separation between male and female samples
(variance explained by PC1 = 18.3% and variance explained by PC2 =
14.7%; PC1 + PC2 = 33%), so all downstream analysis was performed
with male and female datasets separated. Within limma, empirical Bayes
fitting of a linear model and pairwise contrasts were applied to AB, TU,
and WIK strains separately to test for differences between males and
females per strain. These results will be referred to as “sex differences”.
Similarly, a linear model and pairwise contrasts were applied to males
and females separately to test for differences between AB, TU, and WIK
per sex. These results will be referred to as “strain differences”. Pairwise
comparison values for fold change (log-2), average expression (log-10),
p-value, and q-value were averaged for each strain and centered on
zero to facilitate data interpretation. Significant probes were defined as
≥ 2-fold change in expression and Benjamini-Hochberg92 adjusted pvalue ≤ 0.05 (q-value). Standard Agilent array annotations were applied
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to the probes and manually verified across NCBI and Ensembl
databases. Conflicting annotations were resolved by direct overlap of
mapped probes using UCSC’s LiftOver tool as needed. Heatmaps were
produced using the gplots heatmap.2 tool in R (v.3.3.2). Ordering of
genes within heatmaps was performed using Euclidean distances and
complete h clustering without scaling.

Gene ontology analysis
Gene ontology analysis was performed using the Panther
Classification Tool93 developed and maintained by the Gene Ontology
Consortium. Ensembl and NCBI’s ENTREZ gene ID annotations were
assessed for statistical over-representation in the Danio rerio database
(ZFIN last updated 04/2015) using default settings. GO complete
annotations (database released 4/24/2017) for cellular component,
biological

process,

and

molecular

function

were

assessed

with

Bonferroni94 correction for multiple testing. Genes were considered
over-represented at q-value ≤ 0.05 and results are presented as fold
enrichment over the Danio rerio reference database.

Results
mRNA expression profiles differ between sexes in two of three strains
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Analysis of total hepatic mRNA expression arrays detected 149
probes representing 141 genes that are significantly different between
AB males and females (Figure 3.2A; Supplementary Dataset 3.1). Of
these, 62 probes have a positive fold change indicating an increased
expression of the transcript in males relative to females and 87 have a
negative fold change indicating an increased expression of the transcript
in females relative to males. Gene ontology analysis of 117 gene IDs
(82.98%) mapping to Danio rerio shows that differences between males
and females in the AB strain occur largely at the endoplasmic reticulum
membrane (6.40-fold enriched, q-value = 3.01 x 10-3). The biological
processes of response to estradiol (87.14-fold enriched, q-value = 2.03
x 10-2), cellular response to estrogen stimulus (74.36-fold enriched, qvalue = 1.00 x 10-9), lipid transport (22.49-fold enriched, q-value =
1.25 x 10-9), small molecule biosynthetic processes (10.46-fold
enriched, q-value = 8.01 x 10-4), and monocarboxylic acid metabolic
processes (7.88-fold enriched, q-value = 2.98 x 10-2) are statistically
over-represented in the dataset and are largely driven by lipid
transporter activity (29.05-fold enriched, q-value = 3.99 x 10-10) and
oxidoreductase activity (4.79-fold enriched, q-value = 9.63 x 10-4).
Between WIK males and females, 72 probes representing 67
genes are significantly different (Figure 3.2B; Supplementary Dataset
3.2). Of these, 23 probes have a positive fold change indicating an
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increased expression of the transcript in males relative to females and
49 have a negative fold change indicating an increased expression of
the transcript in females relative to males. Gene ontology analysis of 58
gene IDs (86.57%) mapping to Danio rerio shows that differences
between males and females in the WIK strain are not restricted to one
cellular compartment, but encompass biological processes including
response to estradiol (>100-fold enriched, q-value = 2.44 x 10-3),
cellular response to estrogen stimulus (>100-fold enriched, q-value =
7.38 x 10-8), hormone biosynthetic processes (>100-fold enriched, qvalue = 1.30 x 10-2), and lipid transport (37.80-fold enriched, q-value
= 5.23

x 10-10). Similar to AB, these over-represented biological

processes in WIK are largely driven by lipid transporter activity (42.61fold enriched, q-value = 3.51 x 10-8). Interestingly, at our cutoff values
of a minimum of 2-fold change in expression and q-value = 0.05, there
are no probes that are significantly different between TU males and
females. This is most likely due to a wider variation in the TU gene
expression dataset.
Overlapping the differentially expressed probe sets from both AB
and WIK produces a set of 40 probes mapping to 36 genes that are
differentially expressed between males and females, regardless of strain
(Figure 3.2C; Supplementary Dataset 3.3). Of these, only 6 probes have
a positive fold change indicating an increased expression of the
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transcript in males relative to females and 34 have a negative fold
change indicating an increased expression of the transcript in females
relative to males. Examples of mRNA transcripts conserved across
strains include the protein responsible for converting androstenedione
to testosterone (hsd17b3) in males and an egg yolk precursor (vtg1-7)
and

estrogen

receptor

(esr1),

two

transcripts.
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well-known

female-specific

Figure 3.2: Top 20 most significant differentially expressed genes
between sexes. Positive fold change values indicate higher mRNA gene
expression in males, as compared to females. Negative fold change
values indicate higher mRNA gene expression in females, as compared
to males. A) In AB the top 20 q-values range from 0.0049 to 0.0062. B)
In WIK the top 20 q-values range from 0.0030 to 0.0150. C) Regardless
of strain the top 20 q-values range from 0.0081 to 0.0164. Fold change
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values were averaged between male and female datasets. See
supplementary datasets 1-3 for gene symbol definitions.
mRNA expression profiles differ between strains
Within males, 292 probes representing 269 genes are significantly
different between AB, TU, and/or WIK males (Figures 3.3A and 3.4;
Supplementary Dataset 3.4). Seventy-three (73) probes varied between
TU and WIK (AB = 0 fold-change), 117 probes varied between AB and
WIK (TU = 0 fold-change), and 102 probes varied between AB and TU
(WIK = 0 fold-change). Within the strains, the percentage of transcripts
with significantly increased expression accounted for 49.2-62.5% of the
mRNA transcripts, with a mean of 56.3%. Gene ontology analysis of 237
gene IDs (88.10%) mapping to Danio rerio shows that differences
between AB, TU, and/or WIK males are not restricted to one cellular
compartment or molecular function, but are over-represented by the
biological process of circadian regulation of gene expression (45.89-fold
enriched, q-value = 7.20 x 10-3).
In females, 220 probes representing 212 genes are significantly
different between AB, TU, or WIK (Figures 3.3B and 3.4; Supplementary
Dataset 3.5). Fifteen (15) probes varied between TU and WIK (AB = 0
fold-change), 80 probes varied between AB and WIK (TU = 0 foldchange), and 125 probes varied between AB and TU (WIK = 0 foldchange). Within the strains, the percentage of transcripts with
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significantly increased expression accounted for 57.0-67.5% of the
mRNA transcripts, with a mean of 60.5%. Gene ontology analysis of 183
gene IDs (86.32%) mapping to Danio rerio shows that differences
between AB, TU, and/or WIK females occur largely at the endoplasmic
reticulum membrane (5.32-fold enriched, q-value = 9.58
Biological

processes

affected

include

protein

targeting

x 10-4).
to

the

endoplasmic reticulum (49.52-fold enriched, q-value = 5.06 x 10-3),
membrane assembly (31.28-fold enriched, q-value = 3.07 x 10-2), and
single-organism metabolic processes (2.50-fold enriched, q-value =
3.27 x 10-3). These over-represented biological processes are largely
driven by catalytic activity (1.72-fold enriched, q-value = 4.34 x 10-3).
Overlapping the differentially expressed probe sets from both
males and females produces a set of 63 probes representing 59 genes
that are differentially expressed between AB, TU, and WIK regardless of
sex (Figures 3.3C and 3.4; Supplementary Dataset 3.6). Six (6) probes
varied between TU and WIK (AB = 0 fold-change), 29 probes varied
between AB and WIK (TU = 0 fold-change), and 28 probes varied
between AB and TU (WIK = 0 fold-change). More than 50% of the
probes varying between strains, regardless of sex, are attributable to
the AB strain alone. Within the strains, the percentage of transcripts
with significantly increased expression accounted for 46.7-56.6% of the
mRNA transcripts, with a mean of 52.3%. Gene ontology analysis of 52
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gene

IDs

(88.14%)

mapping

to

Danio

rerio

shows

no

over-

representation of any category between AB, TU, and/or WIK, regardless
of sex.
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Figure 3.3: Top 20 most significant differentially expressed genes
between strains. Positive fold change values indicate an increase in
mRNA gene expression and negative fold change values indicate a
decrease in mRNA gene expression. AB is represented by black bars, TU
is represented by checkered bars, and WIK is represented by white bars.
A) In males the top 20 q-values range from 0.0003 to 0.0020. B) In
females the top 20 q-values range from 0.0005 to 0.0014. C) Regardless
of sex the top 20 q-values range from 0.0007 to 0.0077. See
supplementary datasets 4-6 for gene symbol definitions.
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Figure 3.4: Differentially expressed mRNA transcript heatmaps.
Individual heatmaps for males alone, females alone, and shared
between the sexes (global) across AB, TU, and WIK strains. Blue
indicates a positive fold change in expression, red indicates a negative
fold change in expression. Higher saturation indicates stronger positive
or negative fold change.
Discussion
A primary goal of this study was to identify baseline liver mRNA
expression variation between different zebrafish strains. We identified
large differences between strains, with a majority of differentially
expressed mRNA transcripts belonging to AB (Figure 3.5). We
hypothesize that this is due to the additional bottleneck of gynogenesis
in the early establishment of the AB strain and a resulting decrease in
heterozygosity by 34%, as similarly observed in gynogenetic diploid
rainbow trout (Oncorhynchus mykiss)95. Additionally, across all sexes
and strains, approximately 59% of probes show an increase in
expression versus a decrease. The bottleneck of domestication reduces
genetic variation96, but since there is little to no selection acting on these
laboratory strains, we predicted wide variation in expression phenotypes
across strains97 due to the inherent increase in the inbreeding
coefficient98. Although we have described robust gene expression
variation between AB, TU, and WIK, laboratory stocks still have less
diversity between strains when compared to wild-caught zebrafish62.
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Figure 3.5: Summary chart of highly differentially expressed probe
count in males or females across strains. Each bar represents a count
of the mRNA transcripts with 2-fold increased (to the right) or decreased
(to the left) expression by strain in males (top) and females (bottom) in
AB, TU, or WIK. AB is represented by black bars, TU is represented by
checkered bars, and WIK is represented by white bars.
Sex and strain both drive mRNA expression profiles in zebrafish
Sex determination in zebrafish has been argued extensively in the
last decade, but only recently has a six-strain analysis led to a
consensus hypothesis. Our current understanding is that genetic factors
on chromosome 4 drive the ZW/ZZ sex-determining mechanism, but
ultimate sex determination is sensitive to multiple environmental
conditions99. Fascinatingly, AB and TU strains appear to have lost sexspecific signal across the sex-associated region in chromosome 4, so
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factors defining male or female development in these strains are still
unknown. WIK retains the chromosome 4 sex-associated region and has
additional regions on chromosome 14 and several unassembled genomic
scaffolds that are associated with sex determination. Interestingly,
principle component analysis uncovers male and female grouping, as
well as a clear separation of AB away from TU and WIK (Figure 3.6).
Although sex is a major factor in this dataset, the loss of sexdetermining regions in AB and TU do not appear to be driving the
difference in mRNA expression between strains. Interstrain variation is
most likely due to genetic differences caused by population isolation and
bottleneck events during strain establishment. Moreover, we observed
a large portion of differentially expressed mRNA transcripts that were
specific to the AB strain, probably due to the extreme population
bottlenecks and multiple rounds of gynogenesis.
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Figure 3.6: Principle component analysis of samples by sex or strain.
PC1 and PC2 explain 33% of the total variance in the dataset. Sample
identification by sex shows that male and female samples segregate,
with the exception of a single female sample. Sample identification by
strain shows that the AB strain clearly segregates from the TU and WIK
strains.
Lipid transport mRNA transcripts differ between sexes in multiple strains
Genes involved in lipid transport are significantly enriched in
differentially expressed mRNA transcripts between males and females
in both AB and WIK. Among these are members of the vitellogenin
(vtg1-7), retinol binding protein (rbp2a and rbp5), and solute carrier
(slc27a6 and slc25a48) families, as well as a transmembrane trafficking
protein (tmed1a), a kainite glutamate receptor (grik1a), and an
estrogen receptor (esr1). It is important to accurately characterize these
differences between strains because lipid transport is critical in chemical
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messaging, energy storage, temperature maintenance, and formation
of

membranes,

cholesterol

and

prostaglandins.

Furthermore,

vitellogenin is a common marker for endocrine disruption in teleosts;
any variation between expression in this endpoint may drastically affect
interpretation of pharmacological endpoints including estrogenic activity
of xenobiotics.

Circadian rhythm affects mRNA expression in males more than females
Circadian regulation in the zebrafish is directed by light- or darkinduced gene expression in the pineal gland100. Although our study
design did not control for time of day (AB livers were collected in the
morning, while TU and WIK livers were collected in the afternoon), there
are only a small number of genes with circadian rhythm annotations.
Specifically, we identified 295 annotations to 67 genes by searching
AmiGO2101 annotations for any term including the word “circadian”
within zebrafish annotations. In the male dataset there are 6 genes that
annotate to circadian rhythm: arntl1a, bhlhe40, cry5, nfil3-5, nfil3-6,
and nr1d2a. In the female dataset there are only two genes that
annotate to circadian rhythm: arntl1a and cry5.
To expand our analysis of potential circadian effects on our
dataset, we queried circadian rhythm genes annotated in all organisms
within AmiGO2. This expanded our list of potential circadian rhythm
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genes to 2194, but led to no additional genes for the male dataset, and
added only one gene, F7, to the list of genes present in female dataset
that are known to be influenced by circadian rhythm. F7 has been
observed to be regulated by circadian rhythm in the Norway rat 102 and
C57BL/6J mouse103, but a similar regulation has yet to be identified in
zebrafish. Using a comparable approach, we queried a circadian rhythm
RNA-seq dataset in Mus musculus that assessed gene expression in
multiple tissues across time104. We found 9 genes—bhlhe41, ptgr1,
dnaja4, fads2, fkbp5, lmbr1l, nedd41, slc38a4, and stk35—in the mouse
circadian rhythm dataset, but as of yet there is no clear evidence of
oscillation in the expression of these genes in the liver of zebrafish.
Again in this vein of inquiry, we queried the circadian expression profiles
data base (circaDB)105 against 4 mouse liver microarray studies and
found

82

genes

that

have

evidence

of

circadian

regulation

(Supplementary Dataset 3.7).
Expression patterns for the two circadian genes that are shared
between males and females are conserved, with a decrease in
expression of arntl1a and an increase in expression of cry5 in the AB
strain as compared to TU and WIK. This can be explained by the timing
of liver harvest (AB in AM; TU and WIK in PM). What is fascinating,
though, are the other genes affected by circadian rhythms that differed
in the WIK strain only. Bhlhe40 had lower expression in WIK and nfil364

5, nfil3-6, and nr1d2a had higher expression in WIK. If expression of
these genes were solely driven by circadian rhythms, then we would
expect to see similar patterns between TU and WIK. Because this
relationship is lacking, we hypothesize that there are other genetic
factors that regulate the expression of these genes that differ between
strains. This is interesting because experimental design accounts for the
differences in males, but females seem to be less sensitive, suggesting
that males are more sensitive to circadian perturbation than females.
This is not unfounded as sex-specific phenotypes related to circadian
rhythm have been observed in several animals, including behavioral
traits in Drosophila106 and liver metabolism in mice107. Most circadian
oscillations in gene expression are not conserved across tissues and
there are transcriptional “rush hours” prior to dawn and dusk104. Our
samples were collected starting at 4 hours after dawn and ended 3 hours
prior to dusk, which avoids the transcriptional rush hour and minimizes
the maximal effects of circadian-driven transcription. Nonetheless, this
is a reminder that time of day is a factor that should be considered in
zebrafish study design, but that it is not the dominant driver of overall
gene expression.

Functional implications of gene expression variation
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While this is solely a descriptive study on the standing variation
that

exists

in

three

strains

of

zebrafish,

there

are

functional

consequences of variable mRNA expression that should be assessed for
the continued application of zebrafish as a model system. For example,
in this dataset AB males have a greater than expected number of serinetype

endopeptidase

(GO:0004252)

mRNA

transcripts:

prss59.1,

prss59.2, ela2l, try, and cela1. All of these genes have greater than 7fold lower expression in AB as compared to TU or WIK. Loss of
expression of these genes in AB males may indicate a reduction in their
ability to break internal amino acid bonds within polypeptide chains. As
another example, WIK males have greater than 7-fold higher expression
of

two

presynaptic

transcripts:

membrane

assembly

(GO:0097105)

mRNA

nlgn3a and cel.2. Both of these genes are involved in

neuron cell-cell adhesion and neurexin family protein binding. Neuroligin
genes, such as nlgn3a, are important in zebrafish nervous system
development108. Disruption of the neurexin pathway at synapses leads
to autistic-like behavior in mice109 and mutation in nlgn3a in humans
was associated with x-linked Asperger and autism disorders110.
Moreover, a zebrafish model for autism spectrum disorder displays
behavioral differences between strains66. cel.2 is associated with
maturity-onset

diabetes

of

the

young,

type

8,

with

exocrine

disfunction111. Because WIK males exhibit higher expression of these
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genes, they may be compensating for loss of expression of related
genes. A functional follow-up would be to see if neuronal synapses are
enriched in WIK males for neurexin receptors or if there are any
behavioral or exocrine disruption as compared to AB or TU males.
As a final example, AB have an 8-fold decrease in si:dkeyp-73d8.9
mRNA expression, an unknown transcript, in both males and females.
Protein-protein alignment of the predicted amino acid sequence for
si:dkeyp-73d8.9

against NCBI’s non-redundant protein sequence

database indicates that this is most likely a cystatin-like protein.
Cystatins are inhibitors of cysteine proteinases and play a role in
tumorigenesis, kidney function, and modulation of the immune
system112. If all AB fish lack expression of this gene, then AB may be a
better strain to target for development of mutation strains for model
diseases involved in the disruption of the cystatin pathway. Continuation
of describing and validating variation within zebrafish is paramount to
the expansion of the zebrafish model system. This will further elevate
the relevance of zebrafish studies to human health through the
incorporation of multiple strains to simulate wide population variances,
such as seen in human populations.

Conclusions
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Our current understanding of zebrafish as a genetic model is
based on the reference genome, which has only included alternate
sequence loci as of June 2017113. The addition of alternate loci is a
pivotal achievement for zebrafish as a model because it allows the
interpretation of datasets with wide variance due to underlying structure
within the data, such as genetically distinct sub-groups or populations.
Our study goes one step further by describing baseline mRNA expression
differences between zebrafish strains as a physiological interpretation of
established genetic differences between zebrafish strains. We found
major differences between strains and sexes including lipid transport
and circadian rhythms. In the absence of a practical understanding of
intra-population baseline variation, the downstream interpretation of
data becomes skewed, reproducibility becomes increasingly challenging,
and the application of study results become more abstract. Thus, this
study serves as a foundational comparison of the strain-specific
variation in mRNA expression in zebrafish and should be used to inform
future study designs.
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Chapter 4
Response eQTL analysis of low-dose PCB exposure connects
genomic copy number variants to susceptibility
Under review for publication in Aquatic Toxicology

Abstract
Physiological variation induced by genomic copy number variants
(CNV) have received tremendous attention in human disease research,
but little work outside of human health has be conducted. Herein we
assess variable toxicant susceptibility phenotypes in zebrafish (Danio
rerio), using microarrays to identify genomic copy number variants
associated with induced gene expression differences. A micro-exposure
approach (on the ng/L scale) was utilized to uncover secondary sexspecific mechanisms of PCB-126 toxicity without over-inducing the
transcriptionally dominate cytochrome P450 family of xenobiotic
metabolizing enzymes. We found over 30,500 CNV across all individuals,
with approximately 3% of those CNV present at a frequency of ≥ 0.80
per strain. Following 24 hours of 130 ng/L PCB-126 exposure, we found
124 differentially expressed mRNAs in females and 97 differentially
expressed mRNAs in males. Using identified CNV with high penetrance
and PCB-126 induced mRNA expression data, we identified two sexspecific response eQTL, one each in males and females, for this
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phenotype using a linear model analysis. The male response eQTL
involves pre-mRNA processing factor 4 (prpf4) and the female response
eQTL involves dynein cytoplasmic 2 heavy chain 1 (dync2h1). The CNV
in both response eQTL are gains, but the response of the mRNA in each
case differs. In prpf4, mRNA expression decreases when fish are
exposed to PCB-126 while dync2h1 mRNA expression increases
following exposure. This is the first time that either of these genes have
been linked to the PCB-126 susceptibility phenotype and both fall
outside the canonical xenobiotic response pathway. Regardless, either
or both may be linked tangentially with aryl hydrocarbon nuclear
translocator transcriptional response elements.

Introduction
Genetic variation is the cornerstone for building stable populations
resilient

to

environmental

and

ecological

change.

In

sexually

reproducing species, gene flow arising from immigration, emigration,
mutation, and drift maintain genetic variation across populations from
which natural selection determines “winners and losers”. Among most
studied species, the primary genetic research efforts have focused on
variation arising due to single nucleotide polymorphisms (SNPs) or small
insertions and deletions (indels). SNPs and indels can alter phenotypes
by causing changes in the rate of transcription or changes in translated
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protein sequence. Another, and perhaps more important, source of
genetic variation is genomic structural variation, such as copy number
variants (CNV) and inversions, which have been shown to modify
phenotypes by altering gene expression114. Despite their large size and
widespread genomic locations, CNV have received much less research
attention115. A recent comprehensive study using matched DNA and
tissue-specific mRNA expression from the Genotype-Tissue Expression
(GTEx) consortium found that structural variants have larger effects
compared to SNPs and indels, and primarily act via noncoding sequence
variants localized to gene enhancer regions and regulatory elements19.
To interrogate the effect of CNV on complex traits, we utilized a
zebrafish (Danio rerio) model of toxicant susceptibility. The zebrafish
toxicant model is comprised of genetically distinct laboratory strains 4
which exhibit a wide range of susceptibility to PCB-126 (3,3',4,4',5Pentachlorobiphenyl), having developmental toxicity ranging from 9336 ppb across six strains44, and abundant strain-specific CNV46. While
several SNPs, including one located within the primary ligand-target
(aryl hydrocarbon receptor, AHR), have been associated with the PCBsusceptibility phenotype44, no study to date has addressed the role of
CNV for this trait. Toxicant susceptibility and resistance phenotypes are
known to be conserved across mammals, birds, fish, frogs, and
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invertebrates, but manifest through multiple mechanisms116, making
this trait an interesting target to query for CNV effects.
Animals exposed to PCB-126 have increased oxidative damage via
DNA adducts of 7-hydro-8-oxo-2'-deoxyguanosine (8-oxodG)117, which
are generally repaired by the base excision repair pathway118. If adducts
are not repaired prior to DNA replication, there is an increased likelihood
for double strand breaks119 and errors in double strand break repair is
one mechanism by which CNV originate120. To circumvent somatic
induction of CNV, this study utilizes a micro-dose acute exposure
experimental design aimed to induce a xenobiotic response while
avoiding de novo CNV production, as well as other detrimental effects
that have been well-described with PCB-126, including developmental
cardiotoxicity121. Our micro-dosing paradigm in adult zebrafish aims to
elucidate potential alternative mechanisms that may contribute to
observed differences in PCB-126 susceptibility outside of this pathway.
Many studies perform exposures in the microgram per liter range
(generally, 1-1000 ug/L), but negative effects of PCB-126 have been
reported down to 30 ng/L57. By targeting exposures well below the
common ranges observed in zebrafish studies, we aim to uncover
secondary mechanisms outside of the AHR response pathways. Our goal
is to avoid the transcriptionally dominant induction of the cytochrome
P450 family of xenobiotic metabolizing enzymes122, while conserving the
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real-world relevance of low-dose PCB exposure. The United States
Center for Disease Control reports that the geometric mean of PCB-126
in the U.S. population is 16.3 pg/g of lipid (from serum samples)56, while
zebrafish exposed for 48 hours to PCB-126 at 3 ug/L have a body load
of 37.2 ug/g of lipid (from whole embryo homogenates)57. Taken
together, these points indicate that assessment of PCB-126 effects at
higher concentrations is inadequate for understanding the effects of
human PCB exposure and that our micro-dosing model may be better
for elucidating the genetic determinants of PCB-126 susceptibility across
populations from the human health perspective.
Finally, due to its lipophilic nature, PCB-126 will preferentially
sequester to lipid-rich tissue123. Although lipids are largely equivalent
between the sexes, males have higher liver and gonad lipid content than
females124 indicating that sex may act as a modifying factor in the
variable effects of PCB-126 exposure. Studies in aquatic model
organisms have used embryos and larvae due to easily observable
developmental toxicity induced by PCB-126 exposure. The gold standard
used to identify sex in zebrafish is by visual inspection of gonads
because there are currently no reliable genetic markers for sex.
Moreover, because zebrafish are juvenile hermaphrodites until sexual
differentiation at 6 weeks125,126 and because identification of sex in the
exposed larvae is not possible by genetic means, sex-specific factors
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have not been identified in early life stage exposures. For these reasons,
we chose to use sexually mature adult zebrafish to assess the role of
sex on PCB-126 susceptibility in our micro-dosing experiment.

Materials and Methods
Zebrafish Care and Aquatic Exposures
All procedures were approved by the Portland State University
Institutional Animal Care and Utilization Committee in accordance with
the Office of Laboratory Animal Welfare’s Public Health Service policy.
The zebrafish aquatic facility at Portland State University is composed
of a recirculating flow-through housing system (Aquaneering). Water
temperature is maintained at 28.5°C with average pH of 7.4, average
conductivity of 1100 uS, and a 14:10 hour light:dark cycle. Zebrafish
are fed flake food (Tetra) twice daily and supplemented with artemia
and/or rotifers depending on life stage.
Three strains of zebrafish (AB, Tuebingen (TU), and WIK;
n=6/strain/treatment; ntotal=54) locally maintained for four generations
were

exposed

to

three

treatments:

1)

130

ng/L

3,3’,4,4’,5-

pentachlorobiphenyl (PCB-126; Ultra Scientific), 2) 20 ppm (v/v)
acetone127 as a vehicle control, or 3) nothing (naïve). We chose 130
ng/L as our exposure dose because it falls within the range of doses
known to cause sublethal effects in embryos57 and to avoid excessive
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induction of oxidative DNA lesions117. Exposures were performed
statically in 4 L glass beakers for 24 hours, zebrafish were fasted for the
duration of the exposure, and at the end of the exposure period
zebrafish were humanely euthanized for liver and muscle tissue
collection. Tissues were flash frozen in liquid nitrogen and individuals
were confirmed as male or female by visual inspection of gonadal tissue.

Nucleic Acid Extraction and Quantification
DNA was extracted and isolated from white muscle tissue using a
Qiagen DNeasy Blood & Tissue kit per the manufacturer’s protocol. RNA
was extracted and isolated from liver tissue using a Qiagen RNeasy Mini
Kit per the manufacturer’s protocol. DNA and RNA concentration was
measured using a NanoDrop 2000 (Thermo Fisher Scientific) to obtain
260/280 absorbance ratios for DNA = 1.96 ± 0.04 (mean ± SD) and
RNA = 2.09 ± 0.02, indicating that nucleic acid preps were of high
quality for downstream analysis. Archived DNA from Casper strain
zebrafish128 was used as a reference pool of DNA for CNV genotyping.

Phenotyping by mRNA Expression Microarray
100 ng extracted total RNA and control RNA (Agilent RNA SpikeIn Kit, One-Color) was labeled following the manufacturer’s protocol
(Agilent RNA Spike-In Kit, One-Color and Agilent Low Input Quick Amp
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Labeling Kit). Briefly, cDNA was synthesized then cRNA was synthesized
from the cDNA template and concurrently labeled with cyanine 3-CTP
(cy3) dye. Labeled cRNA was purified (Qiagen RNeasy Mini Kit) and
quantified on a NanoDrop 2000. Only labeled samples with a yield of ≥
1.65 ug total cRNA and specific activity of ≥ 6 pmol cy3/ug total cRNA
were hybridized to arrays.
Labeled samples plus a blocking agent (Agilent) were fragmented
for 30 minutes on a 60°C heat block, loaded onto each gasket well,
sealed, and hybridized at 65°C for 17 hours at 10 RPM to Agilent 4x44K
Zebrafish (V3) Gene Expression microarrays. After incubation, arrays
were washed and scanned immediately on an Agilent SureScan
microarray scanner. Data were extracted from arrays using Agilent
Feature Extraction software and assessed for basic quality control
parameters included in the standard Feature Extraction QC report. After
passing quality control requirements data were cleaned and loaded into
R91 (v.3.3.2).
Differential
package90.

The

expression
cyclic

loess

was

determined

method

was

using

used

for

the

limma

inter-array

normalization and replicate probes were averaged within arrays. Males
and females were separated into sex-specific datasets to avoid the
effects

of

transcriptional

differences

between

sexes129.

Pairwise

comparisons were made between strains in the PCB and naïve groups
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after controlling for effects of the vehicle control (PCB minus vehicle).
Differential expression was defined as any probe with a BenjaminiHochberg corrected p-value92 (q-value) ≤ 0.05.

Genotyping by Copy Number Variant Microarray
1 ug extracted DNA or archived Casper DNA was labeled using the
BioPrime Array CGH Genomic Labeling System (Invitrogen) and
fluorescent cy3 or cyanine 5-CTP (cy5) dyes (Perkin Elmer) following
the manufacturer’s protocol. Briefly, DNA was fragmented on a
thermocycler at 95°C for 30 seconds to a target size of 200-500 bp,
reference DNA (Casper) was labeled with cy3, test strain DNA (AB, TU,
or WIK) was labeled with cy5 dye, labeled DNA was cleaned using
Amicon Ultra filter columns (Millipore), and quantified on a NanoDrop
2000. Target parameters for labeled samples were a yield of ≥ 2.8 ug
labeled DNA (equation 4.1) and specific activity of 20-60 (equation 4.2).

Equation 4.1:

[𝐷𝑁𝐴 𝑛𝑔/𝑢𝐿]∗𝑠𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑢𝐿)

Equation 4.2:

[𝑑𝑦𝑒 𝑝𝑚𝑜𝑙/𝑢𝐿]

1000 𝑛𝑔/𝑢𝑔

[𝐷𝑁𝐴 𝑛𝑔/𝑢𝐿]

= 𝑦𝑖𝑒𝑙𝑑

∗ 1000 = 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦

Labeled samples were combined, denatured, prehybridized with
50 ug herring sperm to block excessive hybridization across hyper78

repetitive regions, and hybridized on custom designed 1M aCGH arrays
designed to span the danRer7/Zv9 zebrafish reference genome (Agilent)
at 65°C for 40 hours at 20 RPM. After incubation, arrays were washed
and scanned immediately on an Agilent SureScan microarray scanner.
Data were extracted from arrays using Agilent Feature Extraction
software and assessed for basic quality control parameters included in
the standard Feature Extraction QC report. After passing quality control
requirements data were cleaned and loaded in to Agilent Genomic
Workbench 7.0.
To preprocess arrays, data were passed through a feature filter
(DefaultFeatureFilter

which

removes

probes), an aberration filter

saturated

and

(minimum number

non-uniform

of probes per

amplification or deletion = 3, minimum absolute average log ratio for
amplifications = 0.33, minimum absolute average log ratio for deletions
= 0.5), normalized (legacy center, threshold = 6, bin size = 10, and GC
correction with a 2 Kb window size), and intra-array replicates were
combined. Copy number variant regions were called using the
aberration detection method 2 (ADM-2) algorithms (threshold = 6)
within Genomic Workbench. ADM-2 incorporates quality information
about each log ratio measurement, identifies all aberrant intervals per
sample using high and low log ratios with p-value ≥ 0.05, and
determines optimal size of aberrations. The strength of the ADM-2
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algorithm is its ability to incorporate noisy data and identify small
aberrant regions. CNV calls were processed through a custom perl script
(DataMerge2) using a 50% reciprocal overlap across CNV regions to
identify a copy number gain or loss and regions of 50% overlap (with
shared parents) within CNV46.
Not all CNV are present in all individuals16. Because the PCBsusceptibility phenotype is strain-specific, we assume that CNV that may
be involved in this trait are present at a high frequency within each
strain. Operating under this assumption, we assessed the strain-specific
frequency of CNV and only included high frequency variants (frequency
≥ 0.8) for expression QTL (eQTL) analysis.

eQTL Identification and Response eQTL Confirmation
To identify eQTL we applied a linear model that uses CNV present
at a frequency ≥ 0.80 (15/18) in at least one strain as a predictor
variable and PCB-induced mRNA expression as the response variable.
Specifically, data were loaded into R as four files: CNV genotype per
individual, mRNA expression per individual, start/stop sites for CNV, and
transcription start site for differentially expressed genes,. eQTL were
called using the R package matrixEQTL130. This study utilized a linear
model within matrixEQTL and set cis distances as 2 Mb up- or downstream of identified loci. Significance thresholds for cis and trans eQTL
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were defined using a conservative Bonferroni-corrected p-value94 based
on the number of comparisons in each group (p-value = 10-4 and 10-8,
respectively).
Because our linear model only incorporated mRNA expression
from PCB-exposed individuals, we did additional data visualization to
confirm that the transcriptional response differed with CNV status (as
identified by the eQTL association) and differed in PCB-exposed
individuals as compared to naïve or vehicle-exposed individuals. To
confirm the PCB-specific response of statistically significant eQTL we
plotted the eQTL we had identified by treatment, strain, and CNV status
to look for treatment-specific differences in gene expression131.

Results
PCB-mediated differential gene expression among strains
Baseline

comparison

between

strains

revealed

differential

expression of 1539 probes in males and 2610 probes in females.
Assessment of the effect of PCB exposure resulted in statistically
significant (BH-corrected p-value < 0.05) up- or down-regulation of
expression of 249 probes in males and 831 probes in females. Of these
differentially expressed probes, only 97 in males (38.96%) and 124 in
females

(14.92%)

remained

after

removing

probes

that

were

significantly different between strains before treatment or significantly
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induced by vehicle treatment alone. (Figure 4.1, Supplemental Data
4.1).
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Figure 4.1: Heatmaps of female and male samples indicating relative
mRNA expression induced by 24 hours of PCB-126 exposure. There are
124 probes with significantly differential expression in females and 97
probes in males. Yellow indicates a decrease in expression relative to
naïve controls, blue indicates an increase in expression relative to naïve
controls, and black indicates no change. Probes are organized by
similarity of expression pattern, as determined by Euclidean distance
and complete linkage.
CNV Frequency within Strains
Although microarrays can identify CNV, they are unable to
determine if the variant regions are somatic (de novo) or within the
germline. Because this study aims to identify germline CNV that are
unique across strains, but conserved within strains, we assessed CNV
for frequency by strain to identify targets for eQTL analysis (Table 4.1).
Distribution of CNV throughout strains varied widely, with only 7.91%
of CNV (2418/30587) with a strain-specific frequency ≥ 0.50 and only
0.94% of CNV (287/30587) with a strain-specific frequency of 1.00. Of
the 2.93% of CNV occurring in at least 15 out of 18 individuals per strain
(frequency ≥ 0.80), we identified 200 unique CNV gains and 381 unique
CNV losses across AB, TU, and WIK strains relative to the reference
strain.

Table 4.1: CNV counts per frequency threshold where frequency = #
individuals with CNV/total # of individuals, calculated across strains
independently (AB, TU, WIK). CNV gain or loss is relative to Casper
reference strain. Total indicates number of CNV present in single or
multiple strains, but only counted once.
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frequency
CNV
AB
TU
WIK
total

0.50
gain loss
322
618
1220 419
279
120
1414 1004

0.80
gain loss
65 164
423 94
127 141
514 381

1.00
gain loss
16
34
181 25
24
30
200 87

Cis and trans eQTL driving PCB-susceptibility phenotype
Two cis eQTL were identified in males and one cis eQTL was
identified in females that associate a CNV with a gene that is
differentially expressed between strains (Figure 4.2). The first male
eQTL, prpf4+CNV_155, associated expression of pre-mRNA processing
factor 4 (prpf4) mRNA with CNV_155 (chr5:60447537-60600000,
danRer7/Zv9) with an effect size of -0.32 and a false discovery rate of
0.0004. The second male eQTL, XM_001919485+CNV_717, associated
expression of XM_001919485 (filamin-a, flnb) mRNA with CNV_717
(chr11:43264797-43262726, danRer7/Zv9) with an effect size of 0.22
and a false discovery rate of 0.002.

Finally, the female eQTL,

dync2h1+CNV_343, associated expression of dynein cytoplasmic 2
heavy chain 1 (dync2h1) mRNA with CNV_343 (chr15:4391308743913146, danRer7/Zv9) with an effect size of 0.37 and a false
discovery rate of 0.005.

Relative expression levels and CNV status

across each eQTL are indicated in Table 4.2. Of these, the eQTL
containing CNV_717 did not show any expression differences in
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response to PCB-exposure and was therefore not deemed a true
response eQTL (reQTL).

Figure 4.2: eQTL plots showing CNV status on the x-axis (loss, no
change, or gain) and mRNA expression level on the y-axis for three
statistically significant eQTL. Colors indicate strain type (AB = green, TU
= blue, WIK = orange); symbol indicates treatment (empty circle =
naïve, circle with x = vehicle control, full circle = PCB-126).
Table 4.2: cis eQTL including gene expression and copy number status.
Gene expression values are relative across strains. Copy number status
indicates direction of copy number distribution as compared to the
reference strain, Casper. P-values are unadjusted.
Gene expression
eQTL
prpf4
+CNV_155
XM_001919485
+CNV_717
dync2h1
+CNV_343

Copy number status

AB

TU

WIK

-0.14

-2.82

-0.86

2.72

0.28

0.44

1.80

0.53

0.46

AB
no
change
no
change
gain

TU
gain
loss
no
change

WIK
no
change
no
change
no
change

p-value
1.88E-06
1.95E-05
1.66E-05

Further inspection of reQTL prpf4+CNV_155 placed the CNV
region 1.56 Mb downstream of prpf4 (Figure 4.3) and identified a genic
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region within the CNV (tmem136b). There was no significant differential
expression of tmem136b, either in naïve controls or PCB-126-treated
zebrafish. Additionally, we identified 20 xenobiotic response elements
(XRE, defined as KNGCGTC29) within CNV_155. Associated regions in
reQTL dync2h1+CNV_343 were much closer; CNV_343 was only 0.67
Mb upstream of dync2h1. No genic regions and only a single XRE are
located within the CNV region.

Figure 4.3: Two PCB-sensitivity reQTL identified as a) prpf4+CNV_155
(Chr5:60447537-60600000, Zv9/danRer7) where there is a copy
number gain in TU males and associated reduction in prpf4 mRNA
expression following PCB exposure and b) dync2h1+CNV_343
(Chr15:43189812-43224569, Zv9/danRer7) where there is a copy
number gain in AB females and associated increase in dync2h1 mRNA
expression following PCB exposure.
Discussion
To our knowledge, this is the first study using a micro-dosing
approach to identify sex-specific mechanisms in the conserved PCBsusceptibility phenotype. Previous studies have over-looked sex-specific
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mechanisms, but the reQTL identified in this study point to two
mechanisms responsible for the variability in PCB-126 susceptibility
across populations that are specific to either males or females. We found
prpf4+CNV_155 to be the male-specific mechanism responsive to PCB
exposure. prpf4 facilitates proper spindle assembly during mitosis by
recruiting checkpoint proteins at the kinetochore and loss of prpf4
results in increased aneuploidy and improper mitosis132. prpf4 is a
member of the spliceosome133, but a study in patients with retinitis
pigmentosa found that approximately 50% of prpf4 protein was not
associated with the spliceosome complex134, pointing to other unknown
functions of this gene.
Additionally, prpf4 is associated with heat stress in catfish135 and
ischemic stress in male rats136, so being involved in an exposureinduced stress mechanism is a reasonable conclusion. An increase in
copy number of a region enriched for XRE, such as CNV_155, should
theoretically increase recruitment of transcription factor to that genomic
location, but male TU zebrafish have a significantly lower expression of
prpf4 mRNA when exposed to PCB-126 and are more susceptible to the
toxic effects of PCB than the other strains tested. We hypothesize that
PCB-induced levels of prpf4 mRNA are reduced in TU due to either an
overactive

post-transcriptional

or

post-translational

regulatory

mechanism or by physical blockage of the transcription of prpf4 due to
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recruitment of XRE binding factors. Loss of prpf4 may affect PCB-126induced cellular stress through alternate splicing or by a currently
unknown surrogate function, and therefore result in higher sensitivity to
PCBs.
The gene associated with the female-specific reQTL identified in
this study, dync2h1, is known to be involved in both aminoglycoside137
and temozolomide138 resistance. Additional support for the role of
dync2h1 in PCB-126 resistance is that it is localized to the golgi
apparatus139 where lipids are packaged into vesicles140. In a 30-day
zebrafish dosing study at 150 ng/L, the bioconcentration factor (uptake
rate constant/clearance rate constant) of PCB-126 per animal wet
weight was 105.81 141, illustrating that the bioaccumulation potential for
PCB-126 is high due to lipid partitioning.
AB female zebrafish have an increased copy number of CNV_343
and a concomitant increase in expression of dync2h1 following exposure
to PCB-126. AB zebrafish are also more resistant to PCB-126 than the
other strains tested. Because PCBs are lipophilic compounds, differences
in packaging and transport of lipids may alter the deposition,
metabolism, and excretion of PCBs. This suggests that increased
packaging and transport of PCBs drives PCB-resistance in AB zebrafish.
Interestingly, both prpf4 and dync2h1 have aryl hydrocarbon
nuclear translocator (ARNT) transcription factor binding sites within
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their enhancer regions (as identified by GeneHancer142). ARNT is a welldescribed member of the canonical aryl hydrocarbon receptor (AHR)
PCB-response pathway responsible for transporting ligand-activated
receptors to the nucleus to directly act as transcription factors143,144. So
although these two genes have not been previously implicated in PCBmediated toxicity, they may be linked to the AHR-mediated PCBexposure response mechanism through interaction with ARNT.

Conclusion
This study identified two novel reQTL associated with populationspecific

PCB-sensitivity

using

microarray-based

CNV

and

mRNA

expression data. We found two sex- and strain-specific expressed
targets, namely prpf4 in males of the TU strain and dync2h1 in females
of the AB strain, proximal to CNV regions that each explain
approximately a third of the variation of the observed expression
phenotype. Genetic mechanisms, such as SNPs across the AHR family
in the Atlantic killifish38, have been shown to drive population-specific
resistance to PCBs, but this is the first time that genomic copy number
has been implicated with this trait. Additionally, micro-dose exposure to
PCB-126 allowed us to interrogate secondary mechanisms outside of the
traditional AHR-mediated xenobiotic metabolism pathway and identify

90

novel targets that may act in concert with or independent from
traditional response pathways.
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Chapter 5
Targeted CRISPR-Cas9 Editing of Genomic Copy Number
Modulates PCB-Susceptibility Phenotype

Abstract
PCBs are ubiquitous legacy chemicals that cause health effects in
humans and wildlife. There are several examples of PCB-resistance
between wild populations living in highly contaminated environments
versus clean environments, illustrating an adaptive advantage for
populations that can maintain health in contaminated environments.
Studies in natural populations that have evolved PCB-resistance
identified multiple mechanisms—including SNPs, indels, and fusions—
across the aryl hydrocarbon receptor (AHR) as one of the drivers of the
PCB-susceptibility phenotype. Zebrafish also have variable sensitivity to
PCB-126 across common laboratory strains making them a unique
model system to test the genomic drivers of the PCB-susceptibility
phenotype. A recent study identified genomic copy number across nonAHR regions to associate with the PCB-susceptibility phenotype. Herein
we test the effect of copy number on PBC susceptibility by targeting
duplicated genomic regions in two strains of zebrafish with variable PCB
susceptibility (AB strain = resistant, Tuebingen (TU) strain = sensitive)
using CRISPR-Cas9 mutagenesis. Because the CNV in AB zebrafish
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appears to provide protection from the toxic effects of PCB-126, we
expect that CRISPR-mutant (crispant) AB zebrafish will show higher
sensitivity to PCB-126. Conversely, the CNV in TU zebrafish associates
with increased sensitivity, so we expect crispant TU to have higher
resistance to PCB-126. To test this we injected 1-cell stage embryos
with CRISPR-Cas9 ribonucleic protein complexes targeted to strainspecific copy number variable regions (CNV_343 in AB and CNV_155 in
TU), exposed embryos to variable concentrations of PCB-126, and
assessed developmental toxicity by heart rate, edema, and morphology.
In support of our hypothesis, crispant AB zebrafish showed a reduction
of EC50 values by a factor of 10, from 627.7 to 67.9 ppb PCB-126, as
compared to sham-injected controls. Crispant TU zebrafish had slightly
increased EC50 values, from 35.3 to 47.0 ppb PCB-126, as compared to
sham-injected controls. This study shows clear evidence of CNV as
drivers of the PCB-susceptibility phenotype and is a first step towards
inclusion of genomic CNV into modeling who or what will be susceptible
to PCB-exposure.

Introduction
Polychlorinated biphenyls (PCBs) are aromatic hydrocarbons that
were largely used as insulators, coolants, and plasticizers since their
commercial inception in the 1930s. In 1979 the United States
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Environmental Protection Agency banned the manufacture of PCBs due
to evidence of bioaccumulation, ecological toxicity, observed health risks
following occupational exposures, and a large-scale incident in Yusho,
Japan where over 1000 people were poisoned following consumption of
contaminated cooking oil (reviewed in

53).

Although manufacture of

PCBs was banned in 1979, PCBs are still present in human serum at
concentrations of 16.3 ± 1.6 pg/g or ppt (geometric mean ± 95%
confidence interval) on a lipid-weight basis as measured by a 2000-2004
population survey in the United States56. Current exposure to PCBs is
mostly through consumption of PCB-contaminated fish, dairy, and meat
or exposure to PCB-contaminated air or water145 which can result in
various health effects such as decreased neonatal thymus size 146,
reduced male fertility147, and liver damage148.
In nature, several examples of the rapid evolution of a PCBresistance phenotype have been observed in species living in highly
contaminated environments, such as the Atlantic killifish (Fundulus
heteroclitus) in Superfund sites in New Bedford Harbor36 and the Hudson
River32. Zebrafish (Danio rerio) also exhibit PCB-resistant phenotypes
that are graded across common laboratory strains; some strains are
resistant to PCB exposure and others are extremely sensistive44.
Reports of the genetic mechanisms behind PCB resistance have
identified alterations to the canonical target of PCB, the aryl
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hydrocarbon receptor (AHR)39,44,47, by single nucleotide polymorphisms
(SNPs), short insertions or deletions (indels), or splicing of AHR paralogs
as the major mechanisms involved in this phenotype, but a substantial
percentage of the phenotypic variation is not ascribable to short nucleic
sequence variations in AHR.
An additional type of genomic variation that has been largely
overlooked is copy number variation. Copy number variants (CNV) are
large genomic duplications or deletions, generally on the order of 1 kb
to 1 Mb. CNV span more of than genome than SNPs15, act mainly
through direct interaction with regulatory elements, and have a larger
effect size than SNPs and indels when altering gene expression19.
Zebrafish are an excellent model to use for studies on the effects of CNV
because of their well-described strain-specific CNV46, such as in the
common laboratory strains AB and Tubingen (TU). The goal of this study
is to test the effect of copy number on the PCB-susceptibility phenotype
to further understand genomic drivers of this trait.
Herein we used CRISPR-Cas9 to target two strain-specific CNV
that associate with PCB-susceptibility in zebrafish as identified in a
recent reQTL study149. CNV_155 and CNV_343 are duplications that
associate with changes in expression of dync1h2 or prpf4 following
exposure to PCB-126 (3,3',4,4',5-Pentachlorobiphenyl), respectively.
We hypothesize that reducing copy number at these loci will ablate
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changes in gene expression and “recover” the PCB-susceptibility
phenotype. CNV_155 appears to drive PCB-sensitivity in the TU strain,
which manifests as a very low tolerance to PCB (developmental toxicity
EC50 = 9 ppb PCB-12644). Conversely, CNV_343 appears to drive PCBsensitivity in the AB strain, which manifests as a higher tolerance
(developmental toxicity EC50 = 131 ppb PCB-12644). We predict that
CRISPR-Cas9 targeting to these CNV regions will result in multiple cut
sites (Figure 5.1), loss of the duplicated sequence, and cause a reversion
to the mean phenotype. We expect CRISPR-mutant (crispant) TU fish to
exhibit higher PCB resistance as identified by developmental toxicity
EC50 values higher than controls and crispant AB fish to exhibit lower
PCB tolerance as identified by developmental toxicity EC50 values lower
than controls.

Figure 5.1: CRIPSR-Cas9 targeted at copy number duplicated sites will
target multiple loci and produce multiple double strand breaks.
Methods
Zebrafish Care and Husbandry
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All procedures were approved by the Portland State University
Institutional Animal Care and Utilization Committee in accordance with
the Office of Laboratory Animal Welfare’s Public Health Service policy.
The zebrafish aquatic facility at Portland State University is a
recirculating

flow-through

housing

system

(Aquaneering).

Water

temperature is maintained at 28.5°C with average pH of 7.4, average
conductivity of 1100 uS, and a 14:10 hour light:dark cycle. Zebrafish
are fed flake food (Tetra) supplemented with artemia and rotifers twice
daily.

CRISPR target design and microinjection
Embryos from three strains of zebrafish (AB, Tuebingen (TU), and
WIK) locally maintained for four generations were pair-mated. Embryos
were collected within 15 minutes of fertilization and 1-cell stage
embryos were microinjected with 2 nL of ribonucleoprotein (RNP)
complex150. RNP complex was formed by combining 1 μL [750 ng/μL]
sgRNA (Synthego) and 1 μL [3.84 mg/mL] Cas9 (Integrated DNA
Technologies) in 10 μL of embryo media (15 mM CaCl2·2H2O, 250 mM
NaCl, 10 mM KCl, and 15 mM MgSO4 in ultrapure water) containing 10
ug/mL fluorescein salt and incubating at room temperature for 10
minutes prior to loading injection needles. sgRNA was composed of a 20
bp guide sequence, 3 bp PAM sequence, and an 80-mer SpCas9 scaffold
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designed by Synthego (Table 5.1). Injection needles were pulled from
thin-wall single-barrel borosilicate glass capillaries with internal filament
(ID=0.75 mm, OD=1mm; World Precision Instruments) using a P-80/PC
Flaming/Brown

Micropipette

Puller

(Sutter

Instrument

Co.).

Microinjection needle pull settings were as follows: temp=743, pull=60,
vel=70, time=200. 10 ug/mL fluorescein salt in embryo media was used
as a sham injection control. CRISPR targets were designed using
CHOPCHOP151,152 to fall across identified CNV regions associated with
phenotypically variable trait response eQTLs in two strains: CNV_343 in
the AB strain and CNV_155 in the TU strain149. Successful injection was
defined as visible fluorescence in the animal pole of 3-4 hours post
fertilization (hpf) embryos and embryos were held in a 28.5°C incubator
until phenotype testing at 24 hpf.

Table 5.1: CNV locations and sgRNA target sequence (GRCz10) with
PAM region underlined.
Target
CNV_155
CNV_343

CNV location
chr5:5807993158232394
chr15:4418441744219174

sgRNA target sequence
CTGTATACCATTCCCATATTGGG
GCCCATTTAGCACAGGTATTCGG

sgRNA location
chr5:5813149358131515
chr15:4418706344187257

CRISPR efficiency
For CNV_343 editing, DNA from 10 injected and 3 uninjected AB
embryos was extracted using a modified alkaline lysis HotSHOT method
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optimized for zebrafish tissues153. For CNV_155 editing, DNA from 3
injected, 1 uninjected, and 3 sham injected TU embryos was extracted
using the same method. Primers targeting CNV within identified eQTL
were designed with the Primer3Plus tool77 (Table 5.2) to flank the
CRISPR site (designated as “OUT” primers) or to directly anneal to the
CRISPR target site (designated as “ON”). DNA was assayed in triplicate
on a 96-well plate using Brilliant III SYBR Master Mix with ROX (Agilent).
The PCR cycling protocol included preliminary dissociation (3 minutes at
95°C) and 40 cycles of annealing and extension (95°C for 5 seconds,
60°C for 20 seconds), per manufacturer’s protocol. A dissociation melt
curve was also obtained to confirm single qPCR products. Fluorescence
was measured with a Stratagene Mx3005P (Agilent) and data were
extracted using the Stratagene MxPro data analysis software. Ct values
were extracted by treating replicates as individuals and using the
adaptive baseline plus moving average algorithm enhancements. Ratios
of Ct values for ON primers versus OUT primers (ON:OUT ratio) were
used to assess CRISPR efficiency by comparing ON:OUT ratios for
injected vs control fish (Equation 5.1)154.
Equation 5.1: 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = 𝑂𝑁: 𝑂𝑈𝑇𝑖𝑛𝑗𝑒𝑐𝑡𝑒𝑑 − 𝑂𝑁: 𝑂𝑈𝑇𝑐𝑜𝑛𝑡𝑟𝑜𝑙
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Table 5.2: qPCR primers for validation of CNV regions identified as eQTL
associated with PCB-induced gene expression.
Target
CNV_155
CNV_155
CNV_343
CNV_343

OUT
ON
OUT
ON

Forward primer
AAAAAGGACTGCCGCCAC
CTGTATACCATTCCCATATT
TGGTCCTCCGGAATGGTTTG
GCCCATTTAGCACAGGTATT

Reverse primer
AAATGGCAACAAAACAAACAGA
AAATGGCAACAAAACAAACAGA
TGAATCAGTGACGGTTGGGG
TGAATCAGTGACGGTTGGGG

CRISPR-induced phenotype assessment via PCB exposure
Exposures were performed statically in 96-well plates beginning
at 24 hpf through 120 hpf. Each 96-well plate contained a single strain
of zebrafish and all exposure treatments, each well contained a single
embryo, and plates were maintained in a 28.5°C incubator for the
duration of the assay. Randomly assigned exposure treatments
(n=12/treatment) included media alone, vehicle (0.3% acetone, v,v),
or PCB-126 (3,3',4,4',5-pentachlorobiphenyl) at 1, 5, 25, 125, 625, or
3125 ppb for 24 hours (24-48 hpf). Embryos were exposed from 24 to
48 hpf, exposure media was replaced with clean embryo media at 48
hpf and fifty percent media changes were performed daily thereafter.
Larvae were observed for developmental toxicity endpoints daily on an
inverted microscope at 40X on a Leica DM IRB inverted microscope with
a Leica DFC 450 C digital camera until 120 hpf. Sample sizes for all
treatment groups were n=12, with the exception of AB sham-injected
and TU CRISPR-injected groups at n=4.
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Observations on pericardial edema, yolksac edema, reduced (nonvisible) blood flow to the body, and death were performed at 48, 72, 96,
and 120 hpf. Additionally, heartrate was measured at 120 hpf. Edema
was classified as a 0, 1, 2, 3, or 4 dependent upon the degree of edema
where 0 = no edema, 1 = yolksac or pericardial edema, 2 = the presence
of two of yolksac or pericardial edema or reduced body blood flow, 3 =
yolksac and pericardial edema and reduced body blood flow, 4 = death
following any observation of edema at 48, 72, 96, and 120 hpf.
Abnormal morphology was scored at 48, 72, 96, and 120 hpf as the
presence of curved tail, scoliosis, short body, uneven body symmetry,
death, or unhatched at 120 hpf. Relative EC50 values were calculated
using a probit regression model via the AAT Bioquest EC50 calculator
(www.aatbio.com/tools/ec50-calculator) from combined heart rate,
abnormal morphology, and edema scores at 120 hpf.

Statistical Analyses
Statistical significance of PCB-126 dose-response was determined
for heart rate, abnormal morphology, and edema score and compared
across groups (uninjected, sham-injected, and CRISRP-injected) within
AB and TU separately. Significance of heart rate dose-response was
determined using a one-way ANOVA within the base stats package in R
using the anova() command with type I sum of squares, followed by a
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pairwise

T-test

with

Benjamini-Hochberg

correction

for

multiple

comparisons92. Significance of abnormal morphology was determined
using a Friedman rank sum test for nonparametric statistics on nominal
repeated-measures ratio data155. Significance of edema score was
determined using a one-way repeated measures ANOVA in the base
stats package in R using the aov() command followed by a post-hoc
Tukey test for pairwise comparisons using least-squares means in the
lsmeans package156 in R.

Results
Injection survival rates and CRISPR efficiency
This experiment is comprised of 2569 embryos across two strains
and three injection treatments (Table 5.3). Overall survival of uninjected
embryos was 87.9% in AB and 23.7% in TU, which reflects the overall
reproductive strategies of the two strains: AB tended to have smaller
clutch sizes with higher survival at 24 hpf while TU tended to have large
clutch sizes with decreased survival at 24 hpf. 562 AB embryos and 253
TU embryos were subjected to PCB-susceptibility phenotyping. The
survival rate of injected embryos was 9.11% less in AB and 9.31% less
in TU compared to strain-matched uninjected controls. Addition of
CRISPR RNP to the injection mixture resulted in an additional decrease
of survival by 42.15% in AB and 10.03% in TU. Average CRISPR
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efficiency for CNV_343 RNP was 0.49 (max = 0.85, min = 0.06) and
average CRISPR efficiency for CNV_155 RNP was 0.13 (max = 0.60, min
= -0.31).

Table 5.3: CRISPR injection survival rates. *Confirmed injection values
for naïve AB and TU embryos represent uninjected, fertilized embryos.
strain injection
AB
naïve
AB
sham
AB
CNV_343
TU
naïve
TU
sham
TU
CNV_155

spawn confirmed
24 hr
survival
pairs injections survival
rate
2
471*
414
87.90%
2
66
52
78.79%
8
262
96
36.64%
2
523*
124
23.71%
7
743
107
14.40%
9
504
22
4.37%

Efficacy of PCB-susceptibility phenotype modulation
Heart rate decreased relative to naïve or vehicle-exposed embryos
following exposure to PCB-126 at 625 and 3126 ppb in both uninjected
and sham-injected AB embryos (BH-adjusted p-value < 0.001; Figure
5.2A). In CRISPR-injected AB embryos, heart rate decreased following
exposure to 125, 625, and 3125 ppb PCB-126 relative to controls (BHadjusted p-value < 0.025). Heart rate decreased relative to naïve or
vehicle-exposed embryos following exposure to PCB-126 at 25, 125,
625, and 3126 ppb in both uninjected and sham-injected TU embryos
(BH-adjusted p-value < 0.033; Figure 5.2B). In CRISPR-injected TU
embryos, there was no difference in heart rate at any exposure level
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tested

relative

to

controls

(BH-adjusted

p-value

=

0.6).

See

Supplemental Tables 5.1 and 5.2 for all pairwise p-values for AB and TU
heart rate, respectively.

Figure 5.2: Average heart rate at 120 hpf in beats per minute (bpm).
Error bars represent 95% confidence intervals. A) AB embryos with
CRISPR target to CNV_343, B) TU embryos with CRISPR target to
CNV_155. Injection is indicated by color and symbol where shades of
green represent strain AB, shades of blue indicate strain TU, circles
indicate uninjected embryos, triangles indicate sham-injected embryos,
and squares indicate CRISPR-injected embryos.

104

Abnormal morphology increased relative to naïve or vehicleexposed embryos following exposure to PCB-126 at 3125 ppb in both
uninjected and sham-injected AB embryos (p-value < 0.04). In the
uninjected controls, 75% of AB embryos exposed to 3125 ppb PCB-126
showed abnormal morphology while all other treatment groups were no
different from the controls (Figure 5.3A). This pattern was conserved in
sham-injected AB embryos (Figure 5.3C). In CRISPR-injected AB
embryos, abnormal morphology increased following exposure to 25,
125, 625, and 3125 ppb PCB-126 relative to controls (p-value =
0.0020). CRISPR-injected embryos at 25 ppb, 125 ppb, 625 ppb, and
3125 ppb PCB-126 all had higher percentages of abnormal morphology
(Figure 5.3E) relative to naïve or vehicle-exposed controls indicating
efficacy of CNV_343-targeted RNP to shift the dose-response curve of
abnormal morphology to lower doses than controls.
Abnormal morphology increased relative to naïve or vehicleexposed embryos following exposure to PCB-126 at 25, 125, 625, and
3125 ppb in both uninjected TU embryos, but this was not deemed
significant in a Friedman rank sum test. Abnormal morphology in
uninjected TU was observed in 64% of 25 ppb PCB-exposed, 75% of
125 ppb PCB-exposed, and 92% of 625 and 3125 ppb PCB-exposed
embryos (Figure 5.3B) following the expected higher PCB-sensitivity
phenotype as compared to AB. In sham-injected TU embryos, abnormal
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morphology increased following exposure to 1, 25, 125, 625, and 3125
ppb PCB-126 relative to controls (p-value = 0.0440, Figure 5.3D). In
CRISPR-injected TU embryos only embryos exposed to 125 ppb PCB126 had higher abnormal morphology percentages than controls, but
due to overall toxicity of the CNV_155 RNP (Table 5.3), 88% abnormal
morphology in the control group (Figure 5.3F), and the fact that only 4
exposure groups were tested (naïve, 5 ppb, 25 ppb, and 125 ppb), the
data from CRISPR-injected TU are fairly uninformative probably because
the CNV_155 RNP was highly detrimental to normal development
regardless of PCB exposure.
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Figure 5.3: Percent of larvae with abnormal morphology. Larvae from
strain AB (A,C,E) and TU (B,D,F) were either uninjected (A,B), shaminjected (C,D), or CRISPR-injected at the one-cell stage, exposed to
PCB-126 from 24-48 hpf at 1-3125 ppb, and assessed for abnormal
morphology at 24 hour intervals until 120 hpf. P-values for significance
determined using the nonparametric Friedman rank sum test. Dashed
line indicates the highest abnormal morphology percentage for controls
in each group.
Average edema score increased relative to naïve or vehicleexposed embryos following exposure to PCB-126 at 625 and 3125 ppb
by 72 hpf in uninjected AB embryos (p-value < 2.2e-16) with average
edema scores of 3.2 and 3.5 at 120 hpf, respectively (Figure 5.4A). This
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pattern was conserved in sham-injected AB embryos (p-value <
0.0047), with the addition of an increase in edema scores in embryos
treated with 125 ppb PCB-126 (p-value = 3.27E-08; Figure 5.4C). In
CRISPR-injected AB embryos, average edema score increased following
exposure to 125, 625, and 3125 ppb PCB-126 relative to controls by 72
hpf (p-value < 0.0025; Figure 5.4E). Overall this represents a shift to
earlier and higher toxicity of PCB-126 in CNV_343-targeted embryos
versus sham or uninjected controls. See Supplemental Tables 5.3-5.5
for all pairwise p-values for AB edema scores.
Average edema score increased relative to naïve or vehicleexposed embryos following exposure to PCB-126 at 25, 125, 625 and
3125 ppb by 72 hpf in uninjected and sham-injected TU embryos (pvalue < 0.0003) with average edema scores between 3.6-3.92 in
uninjected embryos and between 2.36-3.3 in sham-injected embryos at
120 hpf (Figures 5.4B,D).

At 120 hpf edema scores in uninjected

embryos were significant in the 5 ppb PCB-exposed embryos (p-value <
3.61-06), but not in sham-injected embryos. In CRISPR-injected TU
embryos, average edema score increased following exposure to 125 ppb
PCB-126 relative to controls at 96 hpf (p-value < 0.03.8; Figure 5.4F),
but due to overall toxicity of the CNV_155 RNP (Table 5.3), high levels
of edema in the unexposed group, and the fact that only 4 exposure
groups were tested, the data from CRISPR-injected TU are not indicative
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of CRISPR-specific effects. See Supplemental Tables 5.6-5.8 for all
pairwise p-values for AB edema scores.

Figure 5.4: Average edema score from 48-120 hpf. Larvae from strain
AB (A,C,E) and TU (B,D,F) were either uninjected (A,B), sham-injected
(C,D), or CRISPR-injected at the one-cell stage, exposed to PCB-126
from 24-48 hpf at 1-3125 ppb, and assessed for edema at 24 hour
intervals until 120 hpf. P-values for significance of the interaction
between the exposure level and day to cause changes in average edema
score determined using repeated-measures ANOVA. Dashed line
indicates the highest average edema score for controls in each group.
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By combining heart rate, abnormal morphology, and edema
scores from 120 hpf, we calculated EC50 values of 512.8 ppb PCB-126
in uninjected AB embryos and 22.5 ppb PCB-126 in uninjected TU
embryos (Figure 5.5). Sham injections slightly increased EC50 values in
both strains, indicating minor toxicity of the injection procedure. CRISPR
injections in AB targeting CNV_343 reduced the EC50 by a factor of 10
to 67.9 ppb PCB-126 relative to sham controls while CRISPR injections
in TU targeting CNV_155 only slightly increased EC50 to 47.0 ppb PCB126 (Table 5.4).

Figure 5.5: Dose-response curves for PCB-126 exposure and calculated
EC50 values using heart rate, abnormal morphology, and edema scores
at 120 hpf in AB (A) and TU (B) embryos. CRISPR target in AB =
CNV_343; CRISPR target in TU = CNV_155.
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Table 5.4: Calculated EC50 values for PCB-126 in nM and ppb with doseresponse equation.

AB uninjected
AB shaminjected
AB CRISPRinjected
TU uninjected
TU shaminjected
TU CRISPRinjected

EC50
(nM PCB-126)

EC50
(ppb PCB-126)

1.571

512.8

Dose-response curve
48.011−14.739
𝑦 = 14.739 +
4.214
𝑥

1.923

627.7

𝑦 = −1.024 +

0.208

67.9

𝑦 = 13.403 +

0.069

22.5

𝑦 = 5.783 +

0.108

35.3

𝑦 = 14.306 +

0.144

47.0

𝑦 = 20.020 +

1+ (
)
1.571
49.078+1.024
𝑥

1.086

𝑥

1.892

1+ (
)
1.923
42.005−13.403
1+ (
)
0.208
50.040−5.783

6.735

𝑥

1+ (
)
0.069
46.115−14.306
𝑥

1.412

1+ (
)
0.108
37.107−20.020
1+ (

5.376
𝑥
)
0.144

Discussion
By targeting CNV_343, a region that is duplicated in the AB strain
and associated with the PCB-susceptibility phenotype, we were
successfully able to reduce the overall sensitivity of crispant AB
zebrafish to PCB-126. We observed AB zebrafish to have an EC50 of
512.8 ppb PCB-126. Sham injections increased the EC50 slightly to 627.7
ppb PCB-126, but this may be a false increase due to small sample sizes
in the AB sham injection groups (n=4/exposure). Injection of CNV_343
RNP resulted in a reduction of EC50 by a factor of 10 to 67.9 ppb PCB126 in crispant AB zebrafish, which supports our hypothesis that
targeting the duplicated genomic region with CRISPR-Cas9 would result
in lower tolerance of PCB-126. We were unable to fully replicate this in
TU zebrafish using CNV_155 as a target, most likely due to the highly
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lethal effects of the CNV_155 RNP and an overall smaller sample size,
but the resulting trend towards an increased EC50 is in agreement with
our predicted results for CNV_155 crispants. Further optimization of
sgRNA:Cas9 ratios and total RNP concentration may ameliorate this
mortality154.
CRISPR-Cas9 genome editing is rapidly becoming a premier tool
in genetic manipulation. Precise targeting is more and more commonly
used to knock down gene expression in a wide variety of model
organisms and cell cultures. CNV have proven to be a nuisance in large
CRISPR screens by generating false-positives due to multiple target cut
sites157–159, but we have utilized this phenomenon to specifically target
a single duplicated region to remove all or some of the duplicated
sequence (Figure 5.1). Our data are not able to reveal the mechanistic
drivers of CRISPR-Cas9 CNV targeted response, but we hypothesize that
CRISPR-Cas9 either induced multiple indels or SNPs at CNV target sites
or simultaneous double-strand breaks resulted in complete excision of
larger genomic regions. Nevertheless, we were able to experimentally
ablate the effects of a non-genic CNV and alter a phenotype.

Conclusion
To our knowledge, this is the first use of CRISPR-Cas9 technology
to target a CNV-driven phenotype. We were able to show clear and
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statistically significant changes in developmental toxicity following
exposure to PCB-126 in crispant AB zebrafish, and to a lesser extent,
changes in crispant TU zebrafish. This study serves as a proof-ofprinciple that CRISPR can be successfully used to target CNV and shows
that

the

PCB-susceptibility

phenotype

is

not

solely

driven

by

modifications to AHR, but is also driven by non-canonical endpoints.
Furthermore, this study highlights the importance of understanding
variation across populations. Genetic variation in human populations
directly affect how we model the effects and prioritize clean-up of
environmental toxicants. By confirming the interaction of CNV on PCBsusceptibility, we hope to continue to advance our understanding of the
complex

relationship

between

genetic

variation

and

toxicant

susceptibility.
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Chapter 6
A Summary of Findings

In the first chapter I introduced the four step risk assessment
process: hazard identification, dose-response assessment, exposure
assessment, and risk characterization. As part of the dose-response
assessment, regulators develop a reference dose for safe levels of
exposure using toxicity data from existing studies and the incorporation
of several uncertainty factors. One of the weaknesses of this approach
is the assumptions made while incorporating uncertainty factors. This
dissertation aims to address the human variation uncertainty factor by
investigating the effects of genomic CNV, a vastly understudied type of
variation, on toxicant susceptibility. By fully understanding the genomic
drivers of toxicant susceptibility, we can better predict the impacts of
intentional

(pharmacologic)

and

unintentional

(occupational

or

environmental) exposures and incorporate our understanding into
clean-up and prevention for sensitive populations.
I begin by expanding our working knowledge of CNV in zebrafish.
Prior knowledge of CNV in zebrafish focused on intrastrain (withinstrain) variation, but did not focus on interstrain (across-strain)
variation. Expanding our knowledge of genomic differences across
zebrafish strains is critical for application mechanisms that drive human
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variation. By using a reciprocal comparison study design, I assessed
CNV across three common strains of zebrafish: AB, Tuebingen, and WIK.
I identified 1351 CNV that cover 1.9% of the most recent genome
assembly (GRCz11), created a publically available track in the UCSC
Genome Browser for CNV visualization and exploration, and predicted
the transcriptional effects of the CNV. Using an extremely conservative
± 5 Kb window, I identified 2200 genes that are likely to be affected
(directly via overlap, or indirectly via transcriptional regulation) by CNV,
illustrating the large impact of CNV on transcriptional variation across
populations.
Knowledge of genomic variation across strains is not useful in
isolation. To move our understanding forward, I characterized the extent
of mRNA expression variation across the same strains that I had
assessed for CNV. One main finding from this work was that male and
female mRNA expression in the liver is vastly different. Moving forward,
I recommend that all analysis using adult zebrafish be partitioned into
male and female datasets, as the overlap of differentially expressed
mRNA between the sexes is only 14%. I found 269 mRNA transcript in
males and 212 mRNA transcripts in females that differed significantly
across strains. Lipid transport was over-represented in the differentially
expressed mRNA datasets, indicating that strains may use different
mechanisms for transport and storage of lipids. This has important
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consequences in the partitioning, sequestration, and transport of
lipophilic compounds, including PCBs.
To evaluate the interactions between CNV and mRNA expression,
I assessed the eQTL of the toxicant-susceptibility phenotype that varies
across strains. To do this I exposed adult zebrafish to micro-doses of
PCB-126 (130 ppt = 130 ng/L = 0.4 pM) and then identified PCB-induced
mRNA expression. Using paired CNV and mRNA expression data from
54 individuals, I was able to identify three statistically significant eQTL.
I then mapped exposure status (unexposed, vehicle control, or PCBexposed) across CNV and mRNA expression plots to identify response
eQTL (reQTL). Using this technique I narrowed my list of QTL down to
two strain-specific mechanisms: one involving prpf4 in the Tuebingen
strain and the other involving dync2h1 in the AB strain. This is an
exciting peek into CNV-based eQTL. As more and more data become
available on CNV across species, I expect a burst of discovery around
CNV as drivers of both simple and complex phenotypes.
To test my identified reQTL as drivers of the toxicant-susceptibility
phenotype, I used targeted CRISPR-Cas9 editing to modify CNV and
then assessed developmental toxicity of PCB-126. Both reQTL identified
CNV duplications that drove a resistant phenotype in AB and a sensitive
phenotype in Tuebingen. By removing or reducing the CNV duplications
with CRISPR-Cas9, I hypothesized that I would be able to reverse the
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susceptibility phenotype. Specifically, AB crispants would be less
resistant (more sensitive) and Tuebingen crispants would be less
sensitive (more resistant) to PCB-126 than their non-modified brethren.
And indeed, the developmental toxicity of PCB-126—as measured by
levels of edema, heart rate, and abnormal morphology—was reversed
in both strains. In AB crispants the EC50 was reduced by a factor of 10
and in Tuebingen crispants the EC50 was increased by 33%, although
increases in Tuebingen were less statistically significant due to high
levels of toxicity. This experiment was a solid proof-of-principle than
CNV are directly involved in the PCB-susceptibility phenotype and that
the mechanistic drivers of this phenotype vary across strains.
Overall this work aims to illuminate how genetic variation affects
phenotype, especially in relation to toxicant susceptibility, using a model
organism to characterize and manipulate a complex phenotype. Broadly,
my goal is to improve the risk assessment process by refining the human
variation uncertainty factor in hazard assessment. This is not a trivial
task. Human variation is vast and complicated. Not only do we vary at
millions of nucleotides, we also vary in our transcriptional response
networks. To simplify my approach, and to be able to directly modify
and test genotype-phenotype interactions, I used the zebrafish as a
model system. To use this system I first needed to define the existing
variation in CNV genotype and baseline transcription, then perturb the
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system with PCBs and identify the transcriptional response. Once
completing those monumental tasks, I identified genetic factors that
drive the PCB-susceptibility phenotype, modified them using CRISPRCas9 genome editing, and tested the resulting phenotype. While I have
not yet attained my overarching goal of improving the risk assessment
process, I have clearly shown that CNV are important drivers of the
toxicant-susceptibility phenotype and can continue in this vein of inquiry
as I move forward in my career.
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Appendix
Supplemental Files
Chapter 1
Supplemental data 1.1 (xlsx)
Annotation of genes with statistically significant changes in gene
expression following PCB exposure in Fundulus heteroclitus plus
annotation of blastn homolog in Danio rerio. CNV status is indicated as
yes/no for direct overlap or indirect association (±100 Kb) of gene. File
size: 19.4 kB
Chapter 2
Supplementary Table 2.1 (xlsx)
qPCR and standard PCR primers, amplicon sizes, and locations. File
size: 10.5 kB
Supplementary Table 2.2 (xlsx)
1941 CNV regions in the Zv8 genome and stepwise liftover to Zv9,
GRCz10, and GRCz11. File size: 215.2 kB
Supplementary Table 2.3 (txt)
Tabular results of Ensembl Variant Effect Predictor of 1355 CNV
(GRCz10) queried against the RefSeq database. File size: 1.8 MB
Chapter 3
Supplementary Dataset 3.1 (xls)
Differentially expressed mRNA transcripts between males and females
in AB. File includes probe name, log fold change, average expression,
p-value, Bonferroni-corrected p-value, and genomic coordinates
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation
files. Entrez gene ID, Ensembl ID, gene symbol, and gene name were
manually confirmed and harmonized. Gene symbols and names
highlighted in pink are differentially expressed in females. Gene symbols
and names highlighted in blue are differentially expressed in males. File
size: 76.0 kB
Supplementary Dataset 3.2 (xls)
Differentially expressed mRNA transcripts between males and females
in WIK. File includes probe name, log fold change, average expression,
p-value, Bonferroni-corrected p-value, and genomic coordinates
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation
files. Entrez gene ID, Ensembl ID, gene symbol, and gene name were
130

manually confirmed and harmonized. Gene symbols and names
highlighted in pink are differentially expressed in females. Gene symbols
and names highlighted in blue are differentially expressed in males. File
size: 54.0 kB
Supplementary Dataset 3.3 (xls)
Differentially expressed mRNA transcripts between sexes regardless of
strain. File includes probe name, log fold change, average expression,
p-value, Bonferroni-corrected p-value, and genomic coordinates
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation
files. Entrez gene ID, Ensembl ID, gene symbol, and gene name were
manually confirmed and harmonized. Gene symbols and names
highlighted in pink are differentially expressed in females. Gene symbols
and names highlighted in blue are differentially expressed in males. Log
fold change, average expression, p-values, and Bonferroni-corrected pvalues are averaged between AB and WIK differential expression
datasets (SupplementaryDataset3.1 and SupplementaryDataset3.2).
File size: 46.5 kB
Supplementary Dataset 3.4 (xls)
Differentially expressed mRNA transcripts between AB, TU, and WIK in
males. File includes probe name, log fold change, average expression,
p-value, Bonferroni-corrected p-value, and genomic coordinates
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation
files. This file also includes calculated log fold change values for each
strain individually by taking the average of the relative log fold change:
(AB.TU-AB.WIK)/2 = ABcalc. Calculated strain-specific log fold change
values were then centered on zero for each probe (ABcenter). Entrez
gene ID, Ensembl ID, gene symbol, and gene name were manually
confirmed and harmonized. Several probes annotate to deprecated gene
IDs; the few that fall into this category are retained in the file, but
identified by strike-through. File size: 184.5 kB
Supplementary Dataset 3.5 (xls)
Differentially expressed mRNA transcripts between AB, TU, and WIK in
females. File includes probe name, log fold change, average expression,
p-value, Bonferroni-corrected p-value, and genomic coordinates
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation
files. This file also includes calculated log fold change values for each
strain individually by taking the average of the relative log fold change:
(AB.TU-AB.WIK)/2 = ABcalc. Calculated strain-specific log fold change
values were then centered on zero for each probe (ABcenter). Entrez
gene ID, Ensembl ID, gene symbol, and gene name were manually
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confirmed and harmonized. Several probes annotate to deprecated gene
IDs; the few that fall into this category are retained in the file, but
identified by strike-through. File size: 144.0 kB
Supplementary Dataset 3.6 (xls)
Differentially expressed mRNA transcripts between strains regardless of
sex. File includes probe name, log fold change, average expression, pvalue, Bonferroni-corrected p-value, and genomic coordinates
(danRer7/Zv9) as reported by Agilent Feature Extract and annotation
files. Log fold change, average expression, p-values, and Bonferronicorrected p-values are averaged between male and female differential
expression datasets (SupplementaryDataset4 and AddtionalFile5).This
file also includes calculated log fold change values for each strain
individually by taking the average of the relative log fold change:
(AB.TU-AB.WIK)/2 = ABcalc. Calculated strain-specific log fold change
values were then centered on zero for each probe (ABcenter). Entrez
gene ID, Ensembl ID, gene symbol, and gene name were manually
confirmed and harmonized. Several probes annotate to deprecated gene
IDs; the few that fall into this category are retained in the file, but
identified by strike-through. File size: 63.5 kB
Supplementary Dataset 3.7 (xls)
Differentially expressed mRNA transcripts that have corresponding
evidence of circadian regulation in 4 mouse liver microarray
experiments from the Circadian Expression Profiles Data Base (circaDB,
http://circadb.hogeneschlab.org/). File includes a tab for each
supplemental dataset (sd1-6) that contains Probeset_ID, Symbol, JTKP,
JTKQ, JTKperiod, JTKphase, and Tissue columns. Probeset ID = unique
to each microarray expression platform. Symbol = gene symbol. JTKP
= JTK_CYCLE p-value. JTKQ = JTK_CYCLE q-value. JTKperiod = period
of circadian oscillation, in hours. JTKphase = phase of circadian
oscillation, in hours. Tissue = original dataset where mogene_liver =
Mouse 1.OST Liver (Affymetrix), liver = Mouse Liver 48 hour Hughes
2009 (Affymetrix), panda_liver = Mouse Liver Panda 2002 (Affymetrix),
and WT_liver = Mouse Wild Type Liver (GNF microarray). “Merge” tab
combines all circadian-driven genes from sd1-6 tabs with duplicates
removed. “Unique” tab lists the gene symbol for the 82 genes described
in this dataset. File size: 97.5 kB
Chapter 4
Supplemental Data 4.1 (xlsx)
Differentially expressed mRNA transcripts between PCB-exposed and
control fish. File includes probe name, log fold change, average
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expression, p-value, Bonferroni-corrected p-value, and genomic
coordinates (danRer7/Zv9) as reported by Agilent Feature Extract and
annotation files. File size: 51.4 kB
Chapter 5
Supplemental Table 5.1 (xlsx)
Heart rate in AB zebrafish. Pairwise t-test p-values with BenjaminiHochberg correction for multiple comparisons. File size: 13.6 kB
Supplemental Table 5.2 (xlsx)
Heart rate in TU zebrafish. Pairwise t-test p-values with BenjaminiHochberg correction for multiple comparisons. File size: 12.4 kB
Supplemental Table 5.3 (xlsx)
Edema score in uninjected AB zebrafish. Pairwise t-test p-values from
Tukey honest significant difference test. File size: 16.0 kB
Supplemental Table 5.4 (xlsx)
Edema score in sham-injected AB zebrafish. Pairwise t-test p-values
from Tukey honest significant difference test. File size: 15.7 kB
Supplemental Table 5.5 (xlsx)
Edema score in CRISPR-injected AB zebrafish. Pairwise t-test p-values
from Tukey honest significant difference test. File size: 17.0 kB
Supplemental Table 5.6 (xlsx)
Edema score in uninjected Tuebingen zebrafish. Pairwise t-test p-values
from Tukey honest significant difference test. File size: 16.4 kB
Supplemental Table 5.7 (xlsx)
Edema score in sham-injected Tuebingen zebrafish. Pairwise t-test pvalues from Tukey honest significant difference test. File size: 16.9 kB
Supplemental Table 5.8 (xlsx)
Edema score in CRISPR-injected Tuebingen zebrafish. Pairwise t-test pvalues from Tukey honest significant difference test. File size: 11.0 kB
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